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that tiny layered structures were responsible for producing the iridescent color in peacock 
feathers (Opticks 1704). More recently, the coloration mechanism in peacock feathers has 
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Before the 19th century it was generally believed that the molecules of life 
could only be produced by organisms. The synthesis of urea in 1828 by 
Friedrich Wöhler was a major breakthrough showing the possibility of 
artificial production of organic compounds. Moreover, this finding was a 
milestone on the road to the belief that, just like non-life, also life is subject 
to the laws of science. Many years later, life has been defined as the 
outcome of an elaborate organization based on trivial ingredients ‡  and 
ordinary forces 1. 
Living systems are set aside from the rest of matter by some unique 
properties. They duplicate, transform energy, metabolize compounds and 
control their exchanges with the surrounding environment. Moreover, they 
are capable to maintain their internal equilibrium when changes occur in the 
outer world: a process commonly known as homeostasis. Various unrelated 
types of disturbance can be discriminated, yet all change the optimal 
functioning conditions of the organism and will be opposed by appropriate 
action.  
A well known cellular stress factor is a raised temperature (or heat shock) 
which causes denaturation of proteins. The adaptation consists of up-
regulation of chaperone and heat shock proteins (Hsps). Hsps are present in 
all organisms assisting the efficient folding of newly synthesized proteins 
and maintaining proteins in a stable conformation, preventing their 
aggregation under stress conditions. In chapter 2 the recycling of ribosomal 
50S·nc-tRNA complexes by Hsp15 is described. This small heat shock 
                                                
‡ Living matter consists of relatively few common chemical elements (C, H, N, O, P and S 
supplemented with some trace elements) 
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protein is extremely up-regulated during thermal stress and has a much 
higher affinity for blocked 50S·nc-tRNA ribosomal subunits compared to 
empty 50S subunits. Heat shock causes translating ribosomes to dissociate 
prematurely, resulting in 50S subunits that carry tRNA covalently attached 
to the nascent chain of an incomplete protein (50S·nc-tRNA). The 50S·nc-
tRNA subunits cannot re-initiate protein synthesis, so translational 
reactivation of a heat shock aborted 50S•nc-tRNA complex requires 
removal of the nc-tRNA by severing of the aminoacylester bond between 
these moieties. Cryo-EM reconstructions and functional assays show that 
Hsp15 reversibly translocates the tRNA moiety from the A- to the P-site of 
stalled 50S subunits. By stabilising the tRNA in the P-site, Hsp15 indirectly 
frees up the A-site, allowing a release factor to land there and cleave off the 
tRNA. 
Another stress factor for an organism is a viral, bacterial or parasitical attack. 
The host organism will attempt to defend itself by raising an immune 
response against the foreign material. Chapter 3 describes the monoclonal 
antibody 54-5C10-A, which is used to diagnose the parasitic disease 
schistosomiasis in humans. The parasitic nematode Schistosoma mansoni 
expresses oligomers of Lewis X trisaccharides, a carbohydrate that normally 
functions, in its monomeric form, as human cell-cell interaction mediator. 
Our structural and biochemical studies indicate a radically different mode of 
binding compared to Fab 291-2G3-A, an antibody specific for monomeric 
Lewis X, thus providing a structural explanation of the diagnostic success of 
54-5C10-A. Chapter 4 and 5 present  the bacterial detoxification enzyme 




-) and chlorate (ClO3
-) as electron acceptors, the bacterium Azospira 
oryzae forms the toxic chlorite (ClO2
-) as a byproduct. To prevent Azospira 
from poisoning itself, this chlorite waste is converted very efficiently into 
chloride and molecular oxygen. The X-ray structure of the chlorite 
dismutase gives insight into the active site of the first described haem 
enzyme performing O-O bond formation as its primary task. Furthermore, 
native mass spectrometry data demonstrate that the oligomeric organization 
of chlorite dismutase is different than the hitherto supposed tetramer. 
In chapter 6 analytical ultracentrifugation, gelfiltration and small-angle X-
ray solution scattering (SAXS) experiments have been used to obtain the 
low resolution structure of full length EB1. The end-binding protein 1 (EB1) 
is a highly conserved group of proteins that uses its localization at the plus-
ends of microtubules to regulate microtubule dynamics and chromosome 
segregation. Our results show that the distance between the centers of 
gravity of the two globular microtubule binding domains of EB1 is about 80 
to 90 Å. This is close to the distance between adjacent tubulin subunits 
along a microtubule protofilament. Binding of EB1 could stabilize the GTP 
or GDP-Pi conformation of tubulin and promote the lateral interactions of 
protofilaments when they assemble into the microtubule lattice.  
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When heat shock prematurely dissociates a translating bacterial ribosome, 
its 50S subunit is prevented from re-initiating protein synthesis by tRNA 
covalently linked the to unfinished protein chain that remains threaded 
through the exit tunnel. Hsp15, a highly up-regulated bacterial heat shock 
protein, is essential for re-activating such dead-end complexes. Here we 
show with functional assays that Hsp15 translocates the tRNA moiety from 
the A- to the P-site of stalled 50S subunits to expose the aminoacylester 
bond between tRNA and nascent chain to ribosome mediated cleavage. 
These assays complement cryo-EM reconstructions of the complex of the 
50S•nc-tRNA sub-unit in the absence and in the presence of Hsp15. By 
stabilising the tRNA in the P-site, Hsp15 indirectly frees up the A-site, 
allowing a release factor to land there and cleave off the tRNA. Such a 
release factor must be stop codon independent, suggesting a possible role 
for a poorly characterised class of putative release factors that are up-
regulated by cellular stress, lack a codon recognition domain and that are 
conserved in eukaryotes.  
Functional proof for the translocating activity of Hsp15 
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2.1 Introduction 
Heat shock up-regulates many proteins that function as chaperones or as 
proteases. Heat shock also increases the transcription of the small heat 
shock protein Hsp15, which is an RNA/DNA binding protein. It targets 
aborted ribosomal 50S subunits rather than misfolded proteins1. Its ~50-fold 
transcriptional increase is even higher than the upshift in expression of well-
characterized heat shock proteins such as GroEL/ES, DnaK and ClpA, 
indicating the high relevance of Hsp15 for adapting to thermal stress2.  
Translating ribosomes can dissociate prematurely upon heat shock, resulting 
in 50S subunits that carry tRNA covalently attached to the nascent chain 
(nc-tRNA) of an incomplete protein that is threaded through the 50S exit 
tunnel‡. These 50S•nc-tRNA subunits cannot re-initiate protein synthesis 
and their accumulation would constitute a problem for the cell. In the intact 
70S ribosome, the tRNA is released from the nascent chain by a release 
factor, which binds in the vacant A-site to cleave the peptidyl esterbond. All 
well-characterised release factors are stop codon dependent3-5, yet the 
release factor that recycles blocked 50S subunits must be stop codon-
independent, as there is no stop codon in the dissociated 50S subunit.  
Rescuing such blocked 50S subunits requires the presence of Hsp15, which 
specifically binds blocked 50S•nc-tRNA ribosomal subunits with high 
affinity (Kd <5 nM), while its affinity for empty, functional 50S subunits is 
                                                          
‡ Presumably tRNA attached to a short peptide would still dissociate, hence we use the term 





significantly lower6. It was established that Hsp15 is not a release factor, 
since the 50S•nc-tRNA•Hsp15 is stable and the tRNA moiety is not 
released7. It remained unclear how Hsp15 discriminates between active and 
aberrantly terminated 50S subunits and how it contributes to recycling 
blocked, non-functional 50S•nc-tRNA complexes.  
In this chapter, puromycin nascent chain release assays are described which 
were used to prove a conjecture based on electron microscopy (EM) 3D 
reconstructions of the complexes involved. These EM results are reported in 
detail elsewhere8. Briefly, the structure of the complex of the 50S•nc-tRNA 
subunit both in the absence and presence of Hsp15 were determined by 
cryo-EM and single particle analysis to resolutions of 14 and 10 Å, 
respectively. The 3D models of these complexes were reconstructed and X-
ray structures of 50S, tRNA and Hsp15 were subsequently fitted into EM 
density maps as described elsewhere8. To summarize the cryo-EM results, 
the 50S•nc-tRNA reconstruction revealed clear additional density located at 
the A site (Figure 1A), corresponding to the tRNA covalently attached to the 
nascent polypeptide chain that is extending through the ribosomal exit 
tunnel. In contrast, the tRNA appears at the P site in the 50S•nc-
tRNA•Hsp15 reconstruction (Figure 1B). 




Figure 1 Reconstructions of: a) the 50S•nc-tRNA complex (the density of tRNA is 
in cyan, 14 Å resolution) and b) the 50S•nc-tRNA•Hsp15 complex (the density of tRNA is 
in cyan and of Hsp15 in blue, 10 Å resolution). The Central Protuberance (CP), the L1 and 
L7/L12 domains and the P- and A-sites are indicated.  
 
 
2.2 Experimental procedures 
2.2.1 Preparation of 50S•nc-tRNA complexes 
The plasmid pUC19Strep3FtsQSecM was transcribed in vitro and translated 
in a membrane-free E. coli cell extract as previously described7. The 
translation mix was loaded directly onto a 38 ml sucrose gradient (10 – 50 
% sucrose in 50 mM Hepes-KOH, 100 mM KOAc, 0.3 mM Mg(OAc)2, pH 
7.5) and centrifuged for 15 hours at 23000 rpm, 4°C in a SW32 Ti rotor 
(Beckman Coulter). The 50S fraction was loaded onto a 300 μl Strep-Tactin 
sepharose column (IBA, Göttingen Germany) equilibrated with buffer 1 (20 
Chapter 2 
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mM Hepes-KOH, 150 mM NH4Cl, 1 mM Mg(OAc)2, 4 mM β-
mercaptoethanol, pH 7.5) at 4°C, eluted with 2.5 mM desthiobiotin in buffer 
2 (20 mM Hepes-KOH, 150 mM NH4Cl, 12 mM Mg(OAc)2, 4 mM β-
mercaptoethanol, pH 7.5) and pelleted by ultracentrifugation (3 h, 55000 
rpm, 4°C, TLA-55 rotor (Beckman)). The 50S•nc-tRNA (50S-nc) pellet was 
dissolved in buffer 2 by gentle shaking on ice. 
 
2.2.2 Purification of Hsp15 
The plasmid pTHZ251 was transformed in E. coli BL21(DE3) and the cells 
were cultured as described. Cells were ruptured by two passages through an 
EmulsiFlex-C5 homogenizer (Avestin) at 15000 psi and the lysate cleared 
by ultracentrifugation (1h, 18000 rpm, 4ºC, Ti70 rotor (Beckman)). The 
supernatant was loaded onto a Q sepharose FF column (GE Healthcare) and 
a phenyl-sepharose column (GE Healthcare) as described1. The purified 
protein was dialyzed against 30 mM Hepes-KOH, 1 mM EDTA pH 7.0, 
concentrated with a Centriplus concentrator (MWCO 3 kDa, Amicon), 
flash-frozen and stored at -80 ºC. 
 
2.2.3 Binding assays of Hsp15 
15 μg 50S-nc, 50S and 70S were incubated in a 1:1 and 1:10 molar ratio 
with purified Hsp15 in buffer 3 (20 mM Hepes-KOH, 100 mM NH4Cl, 25 
mM Mg(OAc)2, pH 7.5) on ice for 30 min. The mix was centrifuged 5 min 
at 14000 rpm in a table top centrifuge at 4°C and then loaded onto a 1.5 ml 
Functional proof for the translocating activity of Hsp15 
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sucrose cushion (30% w/v sucrose in buffer 3). The ribosomes and 
ribosomal subunits were pelleted by ultracentrifugation (5 h, 55000 rpm, 
4°C, TLA-55 rotor (Beckman)). The ribosomal pellet was quantified and 
loaded onto a 16% SDS gel. 
 
2.2.4 Puromycin assay 
60 nM 50S•nc-tRNA•Hsp15 complex in buffer 2 (or buffer 2 with increased 
Mg2+ concentration to 100 mM to favour Hsp15 dissociation) was incubated 
with 2 mM puromycin for 3 h at 37 ˚C. Samples at 45 min intervals were 
withdrawn, mixed with an equal volume of loading buffer and separated on 
a low-pH SDS-based Tris-acetate gel to minimize hydrolysis of the ester 
bond linking tRNA to the nascent chain9. Immunodetection of the nascent 
chain was carried out on PVDF membrane using a Strep-tag monoclonal 
antibody conjugated to horseradish peroxidase (IBA, Göttingen Germany). 
Detection was performed by electrochemiluminescence and spots on the X-
ray films were quantified densitometrically. 
 
2.3 Results and Discussion 
2.3.1 Generation of stable 50S•nc-tRNA complexes 
Stable, homogenous 70S•nc-tRNA complexes were generated by in vitro 
transcription and in vitro translation using the plasmid 
pUC19Strep3FtsQSecM with an N-terminal triple Strep-tag for affinity 
purification7. To span the ribosomal exit tunnel, the FtsQ sequence and the 
Chapter 2 
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17 amino acids-long SecM translational arrest motif were C-terminally 
fused to the affinity tag. The SecM peptide interacts tightly with the 
ribosomal tunnel10 and thereby significantly stabilizes the 70S•nc-tRNA 
complexes, without the need of using chloramphenicol antibiotic. After in 
vitro translation, the translating ribosomes were loaded onto a sucrose 
gradient with low concentration of magnesium ions causing dissociation of 
the 70S•nc-tRNA complexes into 50S•nc-tRNA and 30S (Figure 2A) 
complexes. The 50S•nc-tRNA complexes were further purified and 
separated from empty 50S using a Strep-Tactin sepharose column and 
finally pelleted by ultracentrifugation. The complex with Hsp15 was 
reconstituted by adding a 20–fold molar excess of Hsp15. 
Binding assays confirmed that Hsp15 neither binds 70S ribosomes nor 
empty 50S subunits under the assay conditions (Figure 2B). However, a low 
level of binding of Hsp15 to empty 50S subunits was observed, when the 
sucrose cushion was omitted from the sedimentation assay (not shown). 
This is in agreement with the previously described non-specific nucleic acid 
binding activity of Hsp151. Hsp15 only had a high affinity for 50S subunits 
when they contained nc-tRNA. Also, Hsp15 had to be present in a 1:10 
molar ratio (Figure 2B). 
 
 
Functional proof for the translocating activity of Hsp15 
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Figure 2 
a) Preparation of 50S•nascent 
chain-tRNA complexes (50S-
nc/50S•nc-tRNA). 
Sucrose gradient profile of an 
in vitro translation reaction in 
the presence of 0.3 mM 
Mg(OAc)2. The two peaks 
(50S and 30S) are analyzed on 
a Coomassie-stained SDS gel. 
The presence of the nascent 
chain in the 50S is shown by 
Western blotting (left side) 
using Streptactin-alkaline 
phosphatase conjugate. The 
upper band at ∼34 kDa 
corresponds to nc-tRNA, the 
lower band to the nascent 
peptide alone. b) Binding assay 
of Hsp15. Binding of purified 
Hsp15 to 50S-nc, to 50S and to 
70S was analyzed by ribosomal 
pelleting through a sucrose 
cushion. 
 
As a control (indicated with c), 50S and 70S was loaded alone. Hsp15 did not migrate 
through the sucrose cushion (not shown). Hsp15 was added in a 1:1 and 1:10 molar ratio. 
Hsp15 was found only in the pellet of 50S-nc as indicated with arrows in lanes 1 and 2; in 
the 1:1 molar ratio somewhat less Hsp15 was recovered. As a positive control, 100 ng 
Hsp15 was loaded onto the SDS gel. 
Chapter 2 
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2.3.2 Functional assay of Hsp15 induced tRNA translocation  
The P-site specific antibiotic puromycin is a functional equivalent of a stop 
codon independent release factor. Mimicking the 3’ end of aminoacyl tRNA 
at the A-site, it binds at the A-site and allowing the ribosome to cleave off 
P-site tRNA from the nascent chain, which is transferred to the A-site 
moiety. Puromycin is used in functional assays to distinguish P-site tRNA 
from A-site tRNA and establish A-site occupancy. It was established that 
puromycin abolishes binding of Hsp15 to 50S•nc-tRNA complexes in cell 
extracts6. Presumably, puromycin released the tRNA from the 50S subunit 
and the resulting empty 50S subunits would no longer have a high affinity 
for Hsp15. This observation already indicated that the tRNA must reside in 
the P-site in the 50S•nc-tRNA•Hsp15 complex in cell extracts. Here we 
show that no additional factors were involved: also in highly purified 
50S•nc-tRNA•Hsp15 samples, puromycin was able to cleave off the nascent 
chain (Figure 3).  
N-acetylated Phe-tRNAPhe is a nc-tRNA homologue that can freely diffuse 
into and out of the P-site of 50S subunits, where can react with A-site bound 
puromycin. This reaction proceeds optimally at 100 mM Mg2+ in isolated 
50S subunits, but is slower at lower Mg2+ concentrations12. However, for the 
50S•nc-tRNA•Hsp15 we found the opposite effect: raising the Mg2+ 
concentration reduced the puromycin reactivity.  
 
 
Functional proof for the translocating activity of Hsp15 
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Figure 3 a) Puromycin reaction of 50S•nc-tRNA•Hsp15 at 37 oC in 12 mM and 
100 mM Mg2+. Controls without puromycin do not show any cleavage of the ester bond 
between tRNA and nascent chain, even after 3 hours of incubation. At the outset of the 
reaction, there is already a substantial amount of released nascent chain present (lower 
band). b) The negative natural logarithm of the remaining nc-tRNA was plotted against the 
incubation time. In a first order reaction this is expected to be a straight line, which we 
indeed observe for 2-3 hours after initiating the reaction. The data shown in a) are plotted. 
The puromycin induced cleavage of nc-tRNA was determined by measuring the increase of 
the intensity of the band corresponding to the released nascent chain as a fraction of the 
total intensity corresponding to nascent chain (whether bound to tRNA or not). The higher 
reactivity at 12 mM Mg2+ can be explained by the fixation of tRNA at the P-site by Hsp15 
at this Mg concentration. The experiments were performed in duplicate. 
Chapter 2 
 16 
The cryo-EM structure provided a straightforward explanation of this 
observation. At 100 mM Mg2+, Hsp15 dissociates more easily from 50S•nc-
tRNA complexes6. If Hsp15 is essential for stabilising the tRNA moiety in 
the P-site, as suggested by the structures, its dissociation from the 50S•nc-
tRNA•Hsp15 complex should result in a relocation of the tRNA to the A-
site, where it cannot be cleaved by puromycin. 
 
2.3.3 Recycling ribosomal complexes by Hsp15: discussing the model 
Translational reactivation of a heat shock aborted 50S•nc-tRNA complex 
requires removal of the nc-tRNA by severing of the aminoacylester bond 
between these moieties. In the cell, this hydrolysis requires the tRNA to be 
located in the P-site and a release factor to bind at the vacant A-site. In the 
absence of Hsp15, the tRNA moiety of nc-tRNA, although being somewhat 
disordered, was clearly located in the A-site (Figure 1A). This A-site 
location of the tRNA moiety is further corroborated by a puromycin assay 
(Figure 3). At first sight this is a surprising result, as in the complete 70S 
ribosome, peptidyl tRNA has a preference for the P-site. However, in the 
70S complex, peptidyl tRNA is stabilized at the P-site by extensive contacts 
with the mRNA, 16S RNA and protein residues of the 30S subunit (e.g., 
Ref. 13) and these interactions are obviously absent in the 50S•nc-tRNA 
complex. On the other hand, the A-site location of the tRNA is stabilized by 
additional interactions with residues of the 50S subunit that lie outside the 
peptidyl transfer center, e.g. helix 38 of the ‘A-site Finger’14. Apparently, in 
the absence of the 30S subunit, these interactions are strong enough to direct 
Functional proof for the translocating activity of Hsp15 
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the tRNA moiety in the 50S•nc-tRNA complex to the A-site. Our 
observation explains why the 50S•nc-tRNA complex cannot be recycled: a 
tRNA moiety in the A-site prevents release factors from binding and 
severing the aminoacylester bond between the tRNA and the nascent chain. 
Hsp15 located the tRNA in the P-site. Locked in the P-site, the CCA end of 
the nc-tRNA is optimally positioned in the peptidyl transferase centre for 
hydrolytic attack of its aminoacylester bond by a release factor. The 
translocation of the tRNA to the P-site in the Hsp15 containing complex is 
in full agreement with the puromycin assay (Figure 3) and with puromycin 
sensitivity of dissociated translating ribosomes in cell lysates6. 
Translocation of the nc-tRNA from the A- to the P-site would allow a 
release factor to bind in the A-site. In the 70S ribosome, this translocation 
requires energy: EF-G hydrolyses GTP in the process. Our results indicate 
that in the absence of interactions with the 30S subunit, the binding energy 
of the Hsp15 to the 50S•nc-tRNA complex is sufficient to induce 
translocation.  
Which release factor cleaves the aminoacylester bond between tRNA and 
nascent chain in the 50S•nc-tRNA•Hsp15 complex? All well-characterized 
release factors interact with translating ribosomes and mimic a tRNA 
molecule. They all have a stop-codon recognizing domain at one end and a 
GGQ peptidyl hydrolase domain at the other end, which interacts with the 
peptidyl transferase center of the ribosome3-5;15. In the blocked 50S•nc-
tRNA•Hsp15 complex there is no stop-codon. The putative 15 kD, 140 
aminoacid protein with unassigned function encoded by the yaeJ gene in E. 
coli is a likely candidate to serve as a release factor for 50S*nc-tRNA-
Chapter 2 
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Hsp15 complexes.. In E. coli yaeJ is transcribed immediately ahead of 
cutF/nplE, a factor involved in the extracytoplasmic stress response; both 
apparently belong to the same stress-induced operon16. YaeJ contains the 
conserved GGQ peptidyl hydrolase domain, but lacks a stop-codon 
recognizing domain. Due to the presence of the GGQ motif, YaeJ is placed 
in the same cluster of orthologous groups as the release factors RF1 and 
RF215. Thus, YaeJ could bind to the A site of the 50S•nc-tRNA•Hsp15 
complex and hydrolyze the peptidyl-tRNA ester bond without needing a 
stop codon recognizing domain.  
Residues 10 to 112 of YaeJ have a significant 29% identity and 55% 
similarity with the small human protein ICT1, indicating both share the 
same fold. ICT1 is a 23.6 kD protein with unknown function, but it becomes 
more highly expressed upon neoplastic transformation of colon epithelial 
cells17 and is predicted with high significance (P>0.9) to be targeted to 
mitochondria18. On the basis of its GGQ peptidyl hydrolase domain, ICT1 is 
classified as a putative release factor, even though, like yaeJ, it lacks an 
anticodon recognizing domain. If ICT1 recycles stress-induced 
mitochondrial 50S•nc-tRNA complexes, this might explain its upregulation 
in neoplastic transformation, which is a process requiring the inhibition of 
apoptosis, for instance by the reduction of mitochondrial stress. Details will 
differ, as we did not find a eukaryotic homologue of Hsp15. 
In this work, the SecM peptide was chosen for practical reasons – to 
stabilize the complexes by interaction of the nascent polypeptide with the 
ribosomal tunnel. This is a very unique peptide that causes translational 
arrest, prompting the question whether it is valid to extrapolate the results to 
Functional proof for the translocating activity of Hsp15 
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the general case. However, the presence of the SecM peptide is is necessary, 
though not sufficient, for ribosome stalling: puromycin can still efficiently 
attack a tRNA carrying the SecM peptide7;19, indicating P-site location of 
the tRNA moiety in the 70S complex and a functional peptidyl transfer 
centre. Full stalling by the SecM peptide additionally requires the presence 
of Pro-tRNAPro at the A site19. In the stalled 50S subunit, this second 
condition cannot be met for obvious reasons, so the SecM-stalled nc-
tRNA•50S complex most likely does represent the general case of a heat-
shocked 50S-peptidyl tRNA complex. In addition, the finding that Hsp15 
only has specificity for 50S ribosomal subunits with a tRNA, regardless of 
the sequence of the nascent chain6, further supports the general relevance of 
our finding. In conclusion, we propose that Hsp15 rescues heat-induced 
abortive 50S•nc-tRNA subunits by fixing the tRNA moiety to the P-site, 
regardless of the nature of the nascent chain (Figure 4). This allows a 
(specialized) release factor to bind at the A-site and cleave the 
aminoacylester bond between tRNA and nascent chain. The cleavage allows 
tRNA and nascent chain to diffuse away and the 50S particle to become 




Figure 4 Rescue cycle of the stalled ribosomal 50S subunit. Heat shock can 
erroneously dissociate a translating ribosome into a 30S subunit and a blocked 50S subunit 
carrying a tRNA linked to the unfinished nascent chain (upper right). Here we show that in 
these stalled 50S•nc-tRNA complexes, the tRNA is located at the A-site (bottom right) and 
that the small heat shock protein Hsp15 translocates the tRNA to the P-site (bottom left), 
where it can be liberated by a release factor (top left). 
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Lewis X trisaccharides normally function as essential cell-cell interaction 
mediators. However, oligomers of Lewis X trisaccharides expressed by the 
parasite Schistosoma mansoni seem to be related to its evasion of the 
immune response of its human host. Here we show that monoclonal 
antibody 54-5C10-A, which is used to diagnose schistosomiasis in humans, 
interacts with oligomers of at least three Lewis X trisaccharides, but not 
with monomeric Lewis X. We describe the sequence and the 2.5 Å crystal 
structure of its Fab fragment and infer a possible mode of binding of the 
polymeric Lewis X from docking studies. Our studies indicate a radically 
different mode of binding compared to Fab 291-2G3-A, which is specific 
for monomeric Lewis X, thus providing a structural explanation of the 
diagnostic success of 54-5C10-A. 




Individuals suffering from schistosomiasis raise an immune response 
against a variety of schistosomal carbohydrate elements including Galbeta1-
4(Fucalpha1-3)GlcNAcbeta (Lewis X, LeX), a trisaccharide that is 
expressed both in monomeric and polymeric form in different life stages of 
the schistosomes.1 Schistosomiasis (originally named bilharzia) is the main 
human parasitic disease after malaria in tropical and subtropical areas. 
Infection occurs when cercariae, free-swimming larval forms of 
schistosomes or blood flukes, enter the human host through the skin during 
contact with infected surface water. After penetrating the body the cercariae 
lose their typical forked tail and transform into schistosomula. This altered 
form of the parasite migrates via dermal veins to its final destination within 
the host’s blood circulation where it develops into male and female adult 
worms. Schistosomes have an average life span of 3-5 years (and may 
survive up to 30 years) in the hostile environment of their definitive host. 
Thus, this parasite must have developed remarkable mechanisms to escape 
the immune response of its host. It is thought that the glycoconjugates, 
which are abundantly expressed throughout all life stages of the parasite 
play an important role in many of these escape mechanisms. Parasite 
glycans were found to induce immunomodulatory effects, for instance by 
down-regulating the host-protective TH-1 type immune response or the 
induction of anti-inflammatory responses2. Lewis X both in monomeric and 
oligomeric form is one of the glycoconjugates, which is abundantly 




Figure 1 The antigen recognized by Fab 54-5C10-A is trimeric Lewis X. The repeating 
Lewis X units of the trimeric entity are labeled with Roman numerals. 
 
with a schistosomal infection mount an immune response against the 
different oligomeric forms of Lewis X.4-8 One of the antigens regularly 
released from the gut of adult worms, the circulating cathodic antigen 
(CCA), contains different oligomeric presentations of the carbohydrate 
Lewis X. Most of these presentations contain trimeric Lewis X (Figure 1) as 
part of a longer carbohydrate chain. CCA is excreted in such high amounts 
that sensitive assays to diagnose schistosomiasis are based on its detection 
in an ELISA using anti-Lewis X monoclonal antibodies. Recently a reagent 
strip assay was developed containing anti-CCA Mab 54-5C10-A in its 
capture matrix providing a simple and rapid alternative to the ELISA which 
can be used in endemic areas. The activity and intensity of a schistosomal 
infection can easily be measured by using this reagent strip based on the 
detection of CCA in urine of patients.9 
International efforts to generate anti-schistosome vaccines are part of 
schistosomiasis control programs.10 Despite one potential candidate antigen 
(Sh28 GST) proceeding as far as Phase I and II clinical trials currently no 
effective vaccine against the disease exists.11 Although (medical) treatment 
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with praziquantel cures up to 96% of the patients, reinfection easily takes 
place in most of the endemic areas.11-14 A simple and rapid specific assay is 
therefore required both for initial diagnosis and for the follow-up of 
chemotherapy. 
In this chapter, as a contribution towards the immunology of 
schistosomiasis, we report an analysis of the characteristics of the 
diagnostically important antibody fragment 54-5C10-A. We show that it 
exclusively binds oligomeric Lewis X and not monomeric Lewis X. The 
crystal structure to 2.5 Å demonstrates a binding groove which is able to 
accomodate a trimeric Lewis X molecule. The structure of this trimeric LeX 
binding Fab is compared to the monomeric Lewis X binding Fab 291-2G3-
A.15 
 
3.2 Experimental procedures 
3.2.1 Purification of Fab 54-5C10-A 
The murine Fab 54-5C10-A (IgG3 isotype) was obtained from hybridoma 
cell culture supernatant using standard biochemical methods as described 
before.16 During the purification, isoelectric focusing gel electrophoresis 
showed different isoforms of Fab 54-5C10-A with pI values of 9.3, 7.7 and 
7. This mixture was dialyzed against 20 mM Tris-HCl pH 8 containing 
0.02% (w/v) NaN3 and loaded on an anion exchange column (UNO Q-1, 
Biorad). After elution with a 0-1 M NaCl gradient the flowthrough 
containing the two isoforms with the highest pI values was dialyzed against 
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20 mM glycine buffer pH 9. However, these isoforms could not be 
separated by ion exchange chromatography, so the sample was concentrated 
to 15 mg mL-1 using an Ultrafree Centrifugal Filter Unit (Millipore) and 
used for crystallization. 
 
3.2.2 Immunofluorescence assay 
The immunofluorescence assay (IFA) was carried out on 6 m thick 
sections of S. mansoni adult worms in frozen infected hamster liver tissue. 
Slides were incubated with Mab 54-5C10-A (25 g/ml) in phosphate-
buffered saline (PBS; 0.035 M phosphate, 0.15 M NaCl, pH 7.8), washed, 
and incubated with fluorescein isothiocyanate (FITC) labeled goat anti-
mouse immunoglobulin according to manufacturer’s instructions (Nordic, 
Tilburg, the Netherlands). Images were recorded using a Leica HC 
microscope equipped with a Leica DRC 350FX camera, using the 
appropriate filter combination for FITC fluorescence. 
 
3.2.3 Surface plasmon resonance analysis of 54-5C10-A binding Lewis X-type 
neoglycoconjugates 
Human serum albumin (HSA) neoglycoconjugates containing LNFPIII, di- 
or trimeric LeX were purchased from Isosep AB (Tullinge, Sweden) and 
contained on average 22 mol sugar per mol HSA. LNFPIII or lacto-N-
fucopentaose III (Gal1-4(Fuc1-3)GlcNAc1-3Gal1-4Glc) is a 
pentasaccharide containing Lewis X at its non-reducing end. The BIAcore 
3000 instrument, CM5 sensor chips and an amino coupling kit were 
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purchased from BIAcore AB (Uppsala, Sweden). The Lewis X 
neoglycoconjugates were immobilized on a CM5 sensor chip to a level of 
7,500 RU using the procedures described before.15 Unmodified HSA was 
coupled on one flow channel of each sensor chip as a control. Five L of 
purified 54-5C10-A (1 mg mL-1 in 0.035 M phosphate-buffered saline, PBS) 
was injected. All analyses were performed, corrected and evaluated as 
previously.15 
 
3.2.4 Sequencing of the variable domains 
Standard molecular biology protocols were used to synthesize and amplify 
cDNA of the IgG variable regions from total hybridoma mRNA.15 The 
resulting DNA fragments were cloned in the pSTBlue-1 cloning vector 
according to the protocol of the Perfectly Blunt Cloning Kit (Novagen) and 
transformed into NovaBlue Singles Competent cells. Transformants were 
selected for the kanamycin resistance marker of the cloning vector and for 
the vector carrying an insert with X-Gal (5-bromo-4-chloro-3-indolyl-β-
galactopyranoside). Sequences were obtained commercially (Base Clear, 
Leiden, the Netherlands) by automated dideoxy chain-termination 
technology using the T7 and SP6 promoter primers. 
 
3.2.5 Crystallization and data collection 
Prior to crystallization, the protein sample was filtered through a low 
binding protein 0.22 m filter (Millipore) to remove dust particles and 
protein precipitate. Crystallization trials were performed using the sitting 
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drop vapour-diffusion technique at 295 K using equal volumes of protein 
and reservoir solution.  
Data collection at cryogenic temperatures utilized crystals soaked in a 
solution containing 0.1 M sodium citrate pH 4, 11% polyethylene glycol 
3350 and 22.5% glycerol, flash-frozen in a stream of nitrogen gas at 100 K 
using an Oxford Cryosystems Cryostream device. Data were collected by 
the rotation method for 180 frames with 1.0˚ rotation and 25 seconds 
exposure time per frame, using a MAR Research 165 mm CCD detector on 
beamline BM14 at the European Synchrotron Radiation Facility (ESRF), 
Grenoble, France. The intensities were indexed using MOSFLM17 and 
scaled using SCALA18. 
 
3.2.6 Structure determination 
The structure of Fab 54-5C10-A was solved by molecular replacement with 
MOLREP19 from the CCP4 program suite19;20 using the (uncomplexed) 
structure of the anti-monomeric Lewis X Fab fragment (PDB code 1UZ6) as 
a search model. The molecular-replacement solution was improved by rigid-
body refinement and restrained refinement with REFMAC521. Rebuilding 
was done with ARP/wARP22 and Coot23 and the refinement continued using 
TLS (translation, libration and screw) parameters24. The quality of the final 
model with Rf = 0.20 and Rfree = 0.26, was checked using PROCHECK
25 
and WHATIF26. Illustrations were prepared using Pymol (Figures 4 and 5; 
http://pymol.sourceforge.net/) and Accelrys DS Visualizer (Figure 7; 
http://www.accelrys.com/). 
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3.2.7 Docking trimeric Lewis X into the binding groove 
Currently no crystal structure is available for the trimeric Lewis X antigen 
(Figure 1), hence a 3D model for this saccharide was generated using the 
program Sweet227. The potential binding sites on the solvent accessible 
surface of one Fab 54 molecule (chain A and B) were determined with the 
grid-based cavity prediction implemented in the Molegro Virtual Docker 
(MVD) software (Molegro ApS, Aarhus, Denmark). The cavity 
corresponding to the antigen binding site was selected as the search space 
origin employing a 25 Å radius. Subsequently, the flexible ligand docking 
protocol of the MVD software was used and the resulting poses were 
imported back to MVD for visual inspection. The best pose, having the 
lowest scoring energy (the sum of the ligand-protein interaction energy and 
the internal ligand energy), was further analyzed. 
 
3.3 Results and discussion 
3.3.1 Screening antibodies for their meric Lewis X specificity 
Previously, a large set of anti-schistosome monoclonal antibodies has been 
produced28 and screened by SPR for their interaction with HSA Lewis X 
neoglycoconjugates29. Depending on their interaction behaviour Mabs were 
split up in three groups. Group I binds mono-, di- and trimeric Lewis X 
oligomers, group II interacts with both di- and trimeric Lewis X and group 
III has specific affinity for trimeric Lewis X. The sensorgrams of Mab 291-




Figure 2 SPR sensorgrams of Mab 291-2G3-A (left) and Mab 54-5C10-A (right) 
with mono-, di- and trimeric Lewis X HSA-glycoconjugates. The interaction of the 
antibody was interpreted as binding (+) or non-binding (-). 
 
Figure 2 indicate that mono-, di- and trimeric Lewis X are immunologically 
discernible entities. 
The natural epitope of Mab 54-5C10-A on adult worms S. mansoni worms 
is shown by immunofluorescence (Figure 3). Sections of schistosomes  
 
 
Figure 3 IFA: normal light (left) and immunofluorescence (right) microscopy 
image of a section of an adult S. mansoni worm incubated with Mab 54-5C10-A specific 
for the circulating cathodic antigen (CCA). Fluorescence is specifically observed in the gut 
(G) of the worm. Bar = ~ 100 m. 
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Table I Data-processing statistics for the Fab 54-5C10-A crystal 
X-ray source ESRF BM 14 
Wavelength (Å) 0.95372 
Resolution range (Å) 28.7-2.5 (2.64-2.5)a 
Crystal system monoclinic 
Spacegroup P21 
Unit cell parameters (Å, ˚)  a = 51.4, b = 161.0, c = 53.5 
  = 103.1 
Observed reflections 109380 (15957) 
Unique reflections 29262 (4281) 
Redundancy 3.7 (3.7) 
Completeness (%) 99.9 (100.0) 
Average I/(I) 10.6 (3.2) 
Rmerge
b (%) 5.5 (23.5) 




a Data of the outer resolution shell are given in parentheses 
b Rmerge =  | I - I | /  I, where I is the integrated intensity of an observed reflection and I is the 
average intensity over symmetry-equivalent measurements 
c Matthews coefficient30 
 
incubated with Mab 54-5C10-A and subsequently with FITC-labeled 
secondary antibody showed distinct fluorescent patterns in the gut of the 
worm.  
 
3.3.2 Crystals and structure of the Fab fragment 
Rectangular plate-shaped crystals of maximum dimensions 1.3 x 0.1 x 0.1 
mm3 were grown from 0.1 M sodium citrate pH 4, 11% polyethylene glycol 
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3350. A single crystal was used for the data collection with data-processing 
statistics as shown in Table 1. Analysis of the X-ray diffraction pattern 
indicated that along the k axis reflections were only present if k = 2n, 
identifying the space group as P21. 
The Fab 54-5C10-A structure (later referred to as Fab 54) was 
determined to 2.5 Å resolution. The statistics of the final model (Figure 4) 
are shown in Table 2. The framework region of the Fab 54 shows the usual 
immunoglobulin fold with elbow angles between the VL:VH and CL:CH1 
pseudo-twofold axes of 134.6˚ (chain A,B) and 133.1˚ (chain E,F). Small 
elbow angles like these are the most preferred among  chain type Fabs.31 
 
3.3.2.1 Model quality of the native Fab 54 crystal structure 
In the final model of Fab 54 with Rf = 0.20 and Rfree = 0.26 the amino acid 
residues 126 to 132 of the heavy chain F (and 127 to 131 of heavy chain B) 
are missing. This region is located in a flexible loop with higher than 
average sequence variability according to the variability index for constant 
domain sequences and is often disordered in Fab crystal structures.32 Extra 
density in the vicinity of the protein chain in the model was interpreted as 
glycine, azide and glycerol molecules (used in the crystallization and 
cryoprotection). The structure of Fab 54 has 89 % of all residues in the most 
favoured region, having less than 1 % in the disallowed area of the 
Ramachandran plot. In both light chains the residue Val L51 (Kabat 





Figure 4 Ribbon representation of the Fab fragment 54-5C10-A. Complementarity 
determining regions of the light and heavy chain are depicted as CDR-L1 (red), L2 
(raspberry), L3 (salmon) CDR-H1 (darkblue), H2 (blue) and H3 (lightblue).  
 
numbering), which lies in a turn located between two -strands at the 
beginning of CDR-L2, is a Ramachandran outlier. This is commonly 
observed in other Fabs.33 
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Table II Refinement statistics for the Fab 54-5C10-A crystal 
Refinement Fab 54-5C10-A 
Resolution range (Å) 25.0-2.5 
R-factor 0.203 (0.260) 
Number of Fab molecules in the AU 2 
Number of TLS groups 28 
Protein residues 848 
Water molecules  214 
Ligands 8 glycines/ 3 glycerols /1 azide 
Rms deviations bonds (Å) 0.020 
Rms deviations angles (˚) 1.668 
Average B value (Å2)  
protein/ solvent  43.0/38.9 
glycerol/glycine/azide 51.6/47.0/46.1 
Ramachandran statistics overall (%) 88.8/8.3/2.0/0.8b 
A, B chain 89.6/8.7/1.1/0.5 
E, F chain 88.0/8.2/2.7/1.1 
 
a Data statistics of Rfree are given in parentheses 
b Order: most favoured, additionally allowed, generously allowed and disallowed regions. The 
Ramachandran plot was generated with PROCHECK34 
 
3.3.2.2 Analysis of the Fab 54 hypervariable loops: sequence and 
structure 
The Fab 54 structure showed a rather long and narrow cleft separating the 
hypervariable parts of the heavy and light chain (Figure 5a and 5b). The 
dimensions of this binding channel are approximately 11 Å wide, 7 Å deep 
and 24 Å long (measured in Coot35) contrasting with the relatively small





Figure 5 Comparison of two Lewis X binding sites. The complementarity 
determining regions of the light and heavy chain are depicted as in Figure 4. (a,b) Crystal 
structure of the light and heavy chain from Fab 54-5C10-A with trimeric Lewis X (yellow) 
docked into the antigen binding site. The repeating Lewis X units of the trimeric entity are 
labeled with Roman numerals as in Figure 1 and Table III (c) Crystal structure of the light 
and heavy chain from Fab 291-2G3-A in complex with monomeric Lewis X. (d) Close 
view of the docked trimeric Lewis X showing the intermolecular hydrogen bonding 





binding pocket of Fab 291 (Figure 5c). The latter accommodates the Lewis 
X trisaccharide in a pocket 13 Å wide, 10 Å deep and 15 Å long.15 
It is known that hydrogen bonds and van der Waals contacts are the most 
important factors in stabilizing protein-carbohydrate complexes36 and sugar 
binding sites are therefore usually populated by planar polar side chains 
partaking in hydrogen bond networks. Aromatic side chains can form 
additional hydrogen bonds with sugar residues (see Tyr B57 in Figure 5d) 
and are able to stack with the hydrophobic face of the sugar ring. Indeed 
almost half of the binding site residues in Fab 54 have polar or aromatic side 
chains, but this fraction is identical in the case of Fab 291 (Figure 6) which 
binds a monomer of Lewis X only.  
Analysis of the six CDRs in the Fab 54 sequence classified CDR-L1, L2 
and L3 to the same structural clusters as the corresponding regions in Fab 
291 (4/16A, 1/7A and 1/9A, respectively), but the heavy chain CDRs belong 
to different classes for the two Fabs. CDR-H1 of Fab 54 is a class 3/12A 
and CDR-H2 a 1/9A loop (1/10A and 3/10B in Fab 291, respectively). 
Among the six CDRs, the H3 segment has a distinctive role in antigen 
recognition and the largest diversity in length, sequence and structure.37-39 
Based on the 'H3-rules' describing the relationship between the sequence 
and the CDR-H3 conformation derived from crystal structures, the H3 loop 
of Fab 54 is predicted to be a kinked base.39 Indeed the side chain of Asp 
H101 forms a salt bridge with Arg H94 at the start of CDR-H3. Fab 291 
should also form the kinked base according to the 'H3-rules', but the protein 
model shows an extended structure, probably caused by the presence of the 
charge and size of Arg H99 and Phe H100. 





Figure 6 Sequence alignment of the variable part of the light and heavy chain of 
Fab 54 and Fab 291. CDRs (complementarity determining regions) are shown in bold and 
coloured as in Figures 4 and 5. Residue numbering is according to the Kabat numbering 




3.3.2.3 Modeling trimeric Lewis X into the binding groove 
We were not able to grow crystals containing the trimeric Lewis X antigen, 
neither using co-crystallization nor soaking. We decided to use docking as 
an alternative way to study and predict the Fab 54 interaction with trimeric 
Lewis X. The molecule in the asymmetric unit showing the best 
Ramachandran statistics (chain A and B) was selected and the flexible 
ligand docking protocol of Molegro Virtual Docker resulted in the optimal 
fit of the carbohydrate into the antigen binding site as shown in Figure 5a, 
5b and 5d. All three Lewis X moieties are in contact with the antibody 
paratope, while the middle one seems to anchor with the most and tightest 
hydrogen bonds (Table 3 and Figure 5d). Binding of the trimeric Lewis X 
buries 822 Å2 of the 19170 Å2 solvent accessible surface of one Fab 
molecule, whereas the monomeric Lewis X in the crystal structure of 291-
2G3-A buries 302 Å2 upon binding. In both cases residues of all CDRs are 
involved in hydrogen bonds bridging the antigen. One striking feature of the 
Fab 54 binding groove is that it is dominated by aromatic residues like the 
binding pocket in Fab 291, but more extended over the entire binding 
surface. Aromatic stacking is observed for the Fab 54 amino acids residues 
Phe A32, which interacts with FucII, and Trp B52 with GalII. 
Burial of nonpolar groups at the interface also contributes to the trimeric 
Lewis X binding affinity. The methyl group of the GlcNAcI acetyl function 
is stabilized by the side chains of Val A94 and Tyr B57, while the FucI 
methyl makes a van der Waals interaction with the Ser A27E OG atom. The 
Fab 291 light chain residue Tyr 27d, forming several hydrogen bonds and a  
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L1  Asn A28 ND2 3.2 GlcnacII O7 
L2  Lys A50 NZ 3.2 GalIII O6 
L3  Thr A91 O 2.7 FucII O3 
L3  Thr A91 O 2.7 FucII O4 
L3  His A93 ND1 2.9 FucI O4 
       
H1  Ser B32 O 3.2 FucIII O4 
H2  Asn B53 ND2 3.2 GalII O6 
H2  Asp B55 OD2 3.1 GalII O6 
H2  Tyr B57 OH 3.2 GlcnacI O1 
H2  Tyr B57 OH 2.6 GalII O4 
H3  Gly B97 O 2.6 FucII O2 
 
a Numbering of the sugar residues is according to the Lewis X units (indicated with Roman numerals 
in Figure 1 and 5a) 
 
van der Waals interaction with its monomeric antigen, has been replaced by 
His A27d in Fab 54 to make several van der Waals interactions with the 
FucII methyl group. Furthermore, Ser B32 and Gly B33 in Fab 54 are 
substitutes for the bulkier heavy chain residues Tyr 32 and Trp 33 of Fab 
291. The Ser and Gly side chains create, in concert with Met B34, an 
intermediate hydrophobic surface stabilizing the methyl of FucIII. The 
overall hydrophobic character of the binding groove with a few flanking 
charges involved in hydrogen bonding, is shown in Figure 7. 
The structure of the Lewis X trisaccharide is relatively rigid in solution, 





Figure 7 Molecular surface (colored according to electrostatic potential) for the 
Fab 54 binding site. Proximal residues with the largest charge are labelled. 
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general, the monomer is stabilized by stacking of the hydrophobic face of 
the fucose with the galactose ring. The structure of trimeric Lewis X is 
unknown and therefore the docked model has been analyzed by evaluating 
the torsion angles at the glycosidic linkages (see Table IV). The torsion 
angles were compared to those present in carbohydrate structures in the 
Protein Data Bank using GlyTorsion.41 All torsion angles of the trimeric 
Lewis X model are in the range of most commonly observed angles for the 
Fuc(1-3)Glcnac linkage (of 214 torsions analysed), while the only outlier 
for the Gal(1-4)Glcnac bond (of 120 torsions analysed) is 1 of the third 
Lewis X unit. While the Lewis X units I and II resemble the monomeric 
Lewis X conformation in terms of torsion angles and hydrophobic stacking 
of the fucose with the galactose ring, the third Lewis X differs the most. 
Possibly the absence of hydrophobic stacking in this third unit is 
compensated by hydrogen bonds between GalIII and Lys A50 from the 
CDR-L2 and between FucIII and Ser B32 from CDR-H1. 
The recognition site for the second Lewis X unit (Figure 5a) is comparable 
in appearance to the monomeric binding pocket (Figure 5c). Despite this 
similarity, the mode of binding of the target is different. Lewis X unit II in 
Fab 54 is rotated approximately 180° in the binding groove compared to the 
monomeric Lewis X in Fab 291. The resulting orientation of Lewis X unit II 
is very similar to the binding mode of the Lewis X moiety in the crystal 
structure of the Fab BR96-nLewis Y complex. BR96 is a tumour selective 
antibody binding the nonoate methyl ester derivative of Lewis Y, a 
tetrasaccharide containing Lewis X.42 The presence of at least three Lewis X 
units is essential for binding Fab 54 (Figure 2). The absence 
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Table IV Comparison of the torsion anglesa at the glycosidic linkages in Lewis X 
Torsion angle of trimeric Lewis X unit 
Linkage I II III 
Gal(1-4)Glcnac (	1/1) -67.1/-118.4 -49.8/-72.8 -65.6/-58.8 
Fuc(1-3)Glcnac (	2/2) -59.1/155.2 -72.6/134.7 -58.6/149 
    
 Torsion angle of monomeric Lewis X in 
 crystalb cocrystalc solutiond 
Gal(1-4)Glcnac (	1/1) -70.5/-107.7 -66.7/-114.4 -75/-104 
Fuc(1-3)Glcnac (	2/2) -76.7/139 -82.7/136.7 -81/151 
 
a Torsion angles are defined as 	1 = O5gal-C1gal-O4glcnac-C4glcnac, 1 = C1gal-O4glcnac-
C4glcnac-C5glcnac, 	2 = O5fuc-C1fuc-O3glcnac-C3glcnac and 2 = C1fuc-O3glcnac-C3glcnac-
C4glcnac. 
b Values for one of the two molecules present in the asymmetric unit43 
c Lewis X conformation as observed in one of the two Fab291-Lewis X complexes present in the 
asymmetric unit15 
d Calculated lowest energy conformation44 
 
of one or two Lewis X units would leave a considerable part of the binding 
pocket unoccupied. It has been demonstrated for the anti-tumour antibody 
BR96 that even the absence of one hexose unit of its tetrasaccharide antigen 
nLewis Y resulted in the disappearance of binding, while the concerning 
hexose unit is interacting solely with one His residue in the BR96-nLewis Y 
complex.45 
We anticipate that higher oligomeric forms than trimeric Lewis X might 
bind to Fab 54 as well. This requires a movement of CDR-H3 to convert the 
combining site from a 24 Å long channel into one sufficiently extended to 
accomodate additional Lewis X units. However, this is not unlikely to 
happen since structural changes of CDR-H3 side chains up to 15 Å 
movements are known.46;47 




To better understand molecular recognition of trimeric Lewis X, we have 
determined the sequence and the structure of the anti-CCA Fab 54. The SPR 
results from this study clearly demonstrate that the described Fab 54 needs 
at least three repeating units of the Lewis X trisaccharide to bind CCA. We 
have docked this trimeric Lewis X ligand into the groove type antigen 
binding site and conclude that all six CDRs contribute to binding. Together 
with the Fab 291-monomeric Lewis X structure, the current model provides 
a framework for understanding the specificity for the different Lewis X 
antigens involved in schistosomiasis. The crystal structures show a striking 
difference in the morphology of the antigen binding site: a long channel in 
Fab 54 in contrast to a rather shallow binding pocket in Fab 291. In 
addition, the crystal structure of this diagnostic Fab 54 fragment implies that 
a more extended, repeating epitope fits into its binding site. The current 
study has revealed the property of Fab 54 to recognize oligomers of at least 
three Lewis X units which enables the CCA detection from urine while 
excluding cross reactivity with shorter endogenous Lewis X fragments from 
the infected host.  
 
Coordinates  and sequences 
Coordinates and structure factors have been deposited in the Protein Data 
Bank (accession code 2VQ1). The sequences of the variable domain of the 
heavy and light chain have been deposited in the EMBL/GenBank/DDBJ 
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Chlorite dismutase, a multimeric haem-based protein, is one of the key 
enzymes of (per)chlorate reducing bacteria. It is highly active (>2 kU/mg) in 
reducing the toxic compound chlorite into the innocuous chloride anion and 
molecular oxygen. Chlorite itself is produced as the intermediate product of 
(per)chlorate reduction. We have identified the chlorite dismutase gene in 
Azospira oryzae strain GR-1 employing degenerate primers and 
subsequently overexpressed the active enzyme in Escherichia coli. Chlorite 
dismutase was purified, proven to be active, and crystallized using sitting-
drops with PEG 2000 MME, KSCN and ammonium sulfate as the 
precipitants. The crystals belong to space group P21212, with most likely 6 
subunits in the asymmetric unit. Refined unit-cell parameters are a = 164.46, 
b = 169.34, c = 60.79 Å. The crystals diffract X-rays to 2.1 Å resolution on 
a synchrotron-radiation source and a three wavelength MAD dataset has 
been collected. Determination of the chlorite dismutase structure will 
provide insights into the active site of the enzyme, for which no structures 
are currently available.  
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4.1 Introduction 
Azospira oryzae strain GR-1 (DSM 11199) is one of the first described 
perchlorate-reducing bacteria 1;2. The key enzymes of the dissimilatory 
(per)chlorate reducing pathway, (per)chlorate reductase and chlorite 
dismutase (Cld), were originally purified and characterized from this 
organism 3;4. Besides perchlorate (ClO4
-) and chlorate (ClO3
-) it can utilize 
O2, NO3
- and Mn(IV) as electron acceptors, while using various carbon 
compounds, e.g. fatty acids and dicarboxylic acids, or hydrogen as electron 
donor 1.  
Complete reduction of ClO4
- into Cl- and O2 occurs in a few steps: ClO4
- 
is reduced to ClO3
- by a (per)chlorate reductase [EC 1.97.1.1]. 
Subsequently, the same enzyme catalyzes the reduction of ClO3
- to ClO2
-. 
The (per)chlorate reductase has a molecular mass of 420 kD with subunits 
of 95 and 40 kD (in an 33 composition) containing one [3Fe-4S] cluster, 
two [4Fe-4S] clusters and one molybdenum cofactor per heterodimer. 
Although many denitrifying bacteria can reduce ClO3
- to ClO2
-, the latter 
compound is toxic to these cells 3. 
(Per)chlorate respiration is made possible by the action of yet another 
enzyme, chlorite dismutase (EC 1.13.11.49) which reduces the toxic ClO2
- 
to environmentally innocuous Cl- while producing O2. Cld is a multimeric 
protein containing one iron protohaem IX per 30 kDa subunit 4;5. Iron-
protoporphyrin IX or haem is a ubiquitous enzyme cofactor in nature and 
haem-based proteins are known to catalyze a wide range of biologically 
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important reactions in all kingdoms of life 6;7. However, knowledge about 
the biochemistry of the (per)chlorate reductive pathway is still limited.  
Determination of the structure of Cld may offer insights into the 
mechanism of the final step in (per)chlorate reduction. We anticipate that 
the structural analysis will also open up new ways in bioremediative 
technology of oxochlorate contaminated water. 
Here we report the overexpression, purification, crystallization and 
preliminary X-ray analysis of Cld from Azospira oryzae strain GR-1.  
 
4.2 Experimental procedures 
4.2.1 Selection of the cld gene for overexpression 
Azospira oryzae strain GR-1, previously known as bacterial strain GR-1, 
was grown on chlorate containing medium and the native chlorite dismutase 
was purified as described before 5. 
The N-terminal amino acid sequence was determined by selecting the 30 
kD band of the purified, native Cld monomer from a 15% SDS-PAGE gel. 
This sample was subjected to 11 cycles of Edman (phenylisothiocyanate) 
degradation (Eurosequence, the Netherlands).  
The resulting sequence (M/S)QPMQ(P/A)MKIER was reverse translated 
and used to design degenerate forward primers. However, it became also 
clear that the Azospira oryzae Cld N-terminus is nearly identical to that of 
11 N-terminal amino acids of Dechloromonas aromatica Cld, which is 
MQPMQSMKIER. The backward degenerate primer was therefore based on 
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the DNA sequence corresponding to the C-terminus of Dechloromonas 
aromatica Cld. Combination of these primers yielded a 747 basepair 
product in a PCR reaction with Azospira whole cells. The fragment was 
purified on an agarose gel and sequenced (Baseclear, the Netherlands). 
Although the gene amplified by PCR was now available, generating the 
restriction sites and insertion into the plasmid was unsuccessfull. Due to 
these practical problems, the cld gene was chemically synthesized and 
cloned into pET28a using NdeI and BamHI restriction sites, creating the 
vector pET28a-CDBC (Baseclear, the Netherlands) that includes an N-
terminal His tag and a thrombin cleavage site. The resulting expressed 
protein from this plasmid carries 20 extra amino acids at the N-terminus, 
MGSSHHHHHHSSGLVPRGSH. The new construct was sequenced again, 
shown to be free of mutations or other errors and transformed into E. coli 
BL21(DE3)pLysS cells.  
 
4.2.2 Overexpression and purification of Cld 
To produce haem-containing protein for crystallization and subsequent 
structural analysis, 10 ml cultures were grown overnight on a rotary shaker 
(220 rpm) at 310 K. Erlenmeyer flasks with 500 ml LB medium including 
hemin (40 g ml-1), kanamycin (50 g ml-1) and chloramphenicol (25 g ml-
1) were inoculated 1:50 from these overnight cultures. Growth was 
continued under the same conditions until the absorbance at 600 nm reached 
a value of 0.5. The temperature of the incubator was lowered to 303 K and 1 
mM IPTG was added. Cultures were left to grow overnight (approximately 
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16 h) and cells were harvested by centrifugation at 277 K. Pellets were 
frozen immediately for storage prior to purification. 
To purify Cld, cell paste from 0.5 l culture was resuspended in 10 ml of 
buffer A (20 mM Tris-HCl buffer pH 7.5, 500 mM NaCl) with 50 mM 
imidazole. Benzonase (50 units; Sigma-Aldrich) was added to reduce the 
viscosity due to released DNA and cells were disrupted by sonication on ice. 
The lysate was centrifuged and loaded onto a 5 ml HisTrap FF crude 
column. The column was washed with 5 column volumes of 20 mM Tris-
HCl buffer pH 7.5, 500 mM NaCl and 50mM imidazole and the bound 
protein was directly eluted with 20 mM Tris-HCl buffer pH 7.5, 500 mM 
NaCl and 500mM imidazole. After a step elution of five column volumes of 
buffer A supplemented with 500 mM imidazole the Cld was desalted on a 
HiPrep 26/10 column equilibrated with 20 mM Tris-HCl pH 7.5. 
Subsequently, Cld was bound to a resource S cation exchange column, 
washed with the low ionic strength desalting buffer and eluted with a 
gradient of 0 to 1 M NaCl in 20 mM Tris-HCl pH 7.5. A highly 
concentrated, dark red fraction corresponding to active Cld eluted at 
approximately 135 mM NaCl. This solution was loaded onto a HiLoad 
16/60 Superdex 200 prep grade column equilibrated with 20 mM Tris-HCl 
pH 7.5, 135 mM NaCl. At a low flow rate (0.3 ml min-1) the red colored, 
multimeric species was separated from a small amount of colorless 
monomeric Cld. All columns were obtained from Amersham Biosciences 
(Sweden), mounted on an Äktaxpress protein purification system (GE 
Healthcare) and all purification steps were performed at 277 K. The haem 
containing Cld fractions of the gelfiltration step were combined and 
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concentrated to 75 mg ml-1 using an Amicon concentrator. The purified Cld 
was stored in 20 mM Tris-HCl pH 7.5, 135 mM NaCl at 193 K until further 
use. 
To assay the activity of the monomeric and multimeric Cld, one l 
sample (15 mg ml-1) was mixed with an equal volume of a 15 mM ClO2
- 
solution and observed through a microscope. When multimeric Cld was 
used gas bubbles evolved immediately upon mixture of the droplets 
indicating that the multimeric Cld used in the crystallisation experiments is 
in the active form. 
 
4.2.3 Crystallization and data collection 
Prior to crystallization, the protein sample was filtered through a low 
binding protein 0.22 m filter (Millipore) to remove dust particles and 
protein precipitate. Crystallization attempts were made using different 
commercially available screens. Thin needle shaped crystals were observed 
in the JCSG+ screen (Qiagen) condition 81, 0.1M potassium thiocyanate 
and 30 % (w/v) PEG MME2000. This condition was optimised on Q-plates 
using sitting drop vapour-diffusion at 295 K and a grid with 0 - 1.0 M 
potassium thiocyanate, 0 - 35 % (w/v) PEG MME 2000 in a pH range from 
3.6 - 9.0 using different buffers. Therefore one μl of protein (6 mg ml-1 in 20 
mM Tris-HCl pH 7.5, 135 mM NaCl) and 1 μl reservoir solution were 
mixed and equilibrated against 750 μl of the same reservoir solution. Very 




Figure 1 Crystals of Cld grown in 0.1 M MES pH 5.5, 25 % (w/v) PEG MME 2K, 0.3 M 
KSCN, 5 % glycerol and 180 mM ammonium sulfate. Maximum dimensions were reached 
after 7-10 days.  
 
buffer pH 5.5, 25 % (w/v) PEG MME 2000, 0.3 M KSCN. This condition 
was further optimized using the additive screen (Hampton Research). Hence 
1 μl of protein (6 mg ml-1 in 20 mM Tris-HCl pH 7.5, 135 mM NaCl) and 1 
μl reservoir solution (100 mM MES buffer pH 5.5, 25 % (w/v) PEG MME 
2000, 0.3 M KSCN) were mixed with 0.2 μl additive solution. The 
condition with 0.1 M (NH4)2SO4 as the additive resulted in bigger crystals. 
Finally the (NH4)2SO4 concentration was varied between 0.05 M and 0.3 M 
with or without the addition of 5 % (v/v) glycerol.  Triangular plates, cubic 
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and bipyramidal crystals up to approximately 100 × 100 × 100 m3 in size 
were grown from well solutions containing 100 mM MES buffer pH 5.5, 25 
% (w/v) PEG MME 2000, 0.3 M KSCN, 5% (v/v) glycerol and 160-260 
mM (NH4)2SO4. An example of a cubic shaped Cld crystal is shown in 
Figure 1. The two other crystal shapes were also tested but appeared to be of 
less diffraction quality. The data were not sufficient to determine whether 
all these crystal shapes belong to the same space group. 
Prior to data collection at cryogenic temperatures crystals were soaked in 
a solution containing the mother liquor including 16% glycerol and flash-
frozen in a stream of nitrogen gas at 100 K using an Oxford Cryosystems 
Cryostream device. Multiple wavelength anomalous dispersive (MAD) data 
were collected using an ADSC Quantum Q315r detector on beamline ID23-
1 at the ESRF, Grenoble, France. Three wavelengths were chosen near the 
iron-absorption edge based on an X-ray fluorescence scan of the frozen 
crystal. The f component (peak) and the f (remote) were maximized, 
while the f component (inflection) was minimized. Data were collected with 
a 1˚ rotation and 0.2 seconds exposure time per frame. The intensities were 
indexed with MOSFLM 8 and scaled using SCALA 9 from the CCP4 
program suite 10.  
The refined unit-cell parameters are a = 164.46, b = 169.34, c = 60.79 Å and 
analysis of the X-ray diffraction pattern showed that along the h and k axis 
reflections were only present if h, k, = 2n, identifying the space group as P21212. A 
Matthews coefficient 11 of 2.54 Å3/Da suggested the presence of 6 subunits of 28 
kDa in the asymmetric unit, corresponding to 51.6 % solvent content. Statistics 
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could be identified, phases could be obtained and model building has been 
started. The phasing and the structure determination will be described in 
detail in the next chapter. 
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Chlorite dismutase is a key enzyme of perchlorate and chlorate respiration. 
This haem-based protein reduces the toxic compound chlorite in a very 
efficient way into the innocuous chloride anion while producing molecular 
oxygen. A sequence comparison between Cld homologues shows a highly 
conserved family. The crystal structure of Azospira oryzae strain GR-1 
chlorite dismutase is reported to 2.1 Å resolution. The structure reveals a 
hexameric organisation of the Cld while each monomer exhibits a 
ferredoxin-like fold. The six subunits are organized in a ring structure with a 
maximal diameter of 9 nm and an inner diameter of 2 nm. The haem active 
site pocket is solvent accessible both from the inside and the outside of the 
ring. Moreover, a second anion binding site has been identified near the 
active site which could accommodate the assumed reaction intermediate 
ClO for further transformation. 
The environment of the haem cofactor was investigated using EPR 
spectroscopy. Apart from the high-spin ferric signal of the five-coordinate 
resting state enzyme, two low-spin signals were found corresponding to six-
coordinate species. The current crystal structure confirms and complements 
a recently proposed catalytic mechanism that proceeds via a ferryl species 
and a ClO anion. Our structural data exclude co-operativity between the 
iron centers. 
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5.1 Introduction 
Chlorite dismutase (Cld) catalyzes the reduction of the toxic compound 
ClO2 to environmentally innocuous Cl while producing O2. This 
detoxification reaction is an essential step in the dissimilatory perchlorate 
reductive pathway. Recently, (per)chlorate reducing bacteria have attracted 
attention due to their potential usefulness in remediation of water 
contaminated with oxyanions of chlorine. The toxic compounds perchlorate 
(ClO4), chlorate (ClO3), chlorite (ClO2), hypochlorite (ClO) are not 
formed on a large scale in nature. Although traces of perchlorate are found 
in Chile saltpeter, the use of such fertilizer has not been associated with the 
current contamination levels. The occurrence of harmful quantities of 
chloro-oxyanions in surface and groundwaters in the United States is caused 
by the large scale chemical production, the wide range of applications and 
the chemical stability of chlorine anions in water. Most of the ClO4 
contamination in the environment originates from its use in ammonium 
perchlorate as the solid oxidant in rocket propulsion, explosives and 
fireworks 1. ClO3 is used as a herbicide 2;3, and it is released when chlorine 
dioxide (ClO2) is used as a bleaching agent in paper and pulp industry. 
ClO2 is a drinking water disinfection byproduct with potential nervous 
system effects for children and a suspected health risk concerning anemia. 
The Environmental Protection Agency has therefore limited the maximum 
ClO2 concentration in drinking water to one milligram per litre 4. Azospira 
oryzae strain GR-1 (DSM 11199) is one of the first described perchlorate-
reducing bacteria 5;6. This organism and its biochemical pathways that 
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completely reduce ClO4 and ClO3 to Cl plus O2 via the ClO2 
intermediate have been researched for more than a decade. This research 
was inspired by potential practical applications in waste water treatment and 
by fundamental interest in the mechanism of chlorite transformation. The 
key enzymes of the dissimilatory (per)chlorate reducing pathway, 
(per)chlorate reductase and Cld, were originally purified and characterized 
from Azospira oryzae strain GR-1 7;8. It was discovered that complete 
reduction of ClO4 by Azospira oryzae strain GR-1 into Cl and O2 occurs in 
a few steps. First ClO4 is reduced to ClO3 by a (per)chlorate reductase [EC 
1.97.1.1]. Subsequently, the same enzyme catalyzes the reduction of ClO3 
to ClO2. Finally, Cld (EC 1.13.11.49) converts the ClO2 into Cl while 
producing O2. The (per)chlorate reductase contains one [3Fe-4S] cluster, 
two [4Fe-4S] clusters and one molybdenum cofactor per 33 heterodimer 
and produces a water molecule at each successive 2e reduction step. 
Although many denitrifying bacteria can reduce ClO3 to ClO2 using nitrate 
reductase, the latter compound is toxic to these cells 7. 
Cld is a multimeric protein containing one iron protohaem IX per 28 kDa 
subunit 8;9. Intriguing properties of this enzyme are the extraordinary 
specificity for chlorite and the efficiency of the chlorite conversion. 
Moreover, currently Cld is the only known haem-based enzyme which is 
able to perform O-O bond formation catalysis as its primary function. An 
introduction to the current biochemical knowledge about chlorite dismutase 
has been written by Streit and DuBois 10. Very recently a mechanism 
involving a compound I intermediate and subsequent recombination of the 
resulting hypochlorite and compound I was proposed for the chlorite 
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dismutase reaction. High-valent oxo intermediates were characterized by 
stopped-flow UV-vis spectroscopy in this study 11. Here, we report the 
crystal structure of Cld, new insights into the quaternary state of the protein 
and the structural implications for the proposed catalytic mechanism. 
 
5.2 Experimental procedures 
5.2.1 Cloning, overexpression and purification of Cld from Azospira 
oryzae strain GR-1 
The Cld gene was chemically synthesized without the region coding for the 
signal sequence and then cloned into the pET28a vector, creating the vector 
pET28a-CDBC (BaseClear, the Netherlands). The resulting expressed 
protein from this plasmid includes a His-tag with a thrombin cleavage site, 
extending the amino terminus with 20 extra amino acids: 
MGSSHHHHHHSSGLVPRGSH. The protein used in the crystallisation 
trials was digested with thrombin to remove this linker. Details about the 
cloning, overexpression and purification of Cld have been described 12. The 
specific activity of the purified Cld was 1.5 (± 0.5) × 103 mol ClO2 min-1 
mg-1. 
 
5.2.2 Determination of Stokes radius 
The molecular Stokes radius of Cld was estimated by calibrated gel 
filtration chromatography on an ÄKTAxpress protein purification system 
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(GE Healthcare). A HiLoad 16/60 Superdex 200 prep-grade column 
equilibrated with 20 mM Tris-HCl pH 7.5, 135 mM NaCl was run at a low 
flow rate (0.3 ml min-1). The column was calibrated using the following gel 
filtration standards (Bio-Rad) with known molecular weights and radii: 
thyroglobulin (670 kD, 86.0 Å), bovine gamma globulin (158 kD, 52.3 Å), 
chicken ovalbumin (44 kD, 30.5 Å) and equine myoglobin (17 kD, 19.1 Å) 
13;14. Samples were loaded onto the Superdex column and the relative 
elution volume (−log Kav)
1/2 plotted versus the molecular Stokes radius. The 
partition coefficient, Kav, was calculated from the elution volume of the 
protein, Ve, and the total gel bed volume, Vt, using the expression Kav = (Ve 
− V0)  (Vt − V0). The void volume, V0, was determined by running blue 
dextran (average molecular weight 2000 kD) through the Superdex column. 
 
5.2.3 Mass Spectrometry 
Mass spectrometry (MS) measurements were performed in positive ion 
mode using an electrospray ionization time-of-flight (ESI-TOF) instrument 
(LCT, Waters, UK) equipped with a Z-spray nano-electrospray ionization 
source. Needles were made from borosilicate glass capillaries (Kwik-Fil, 
World Precision Instruments, Sarasota, FL) on a P-97 puller (Sutter 
Instruments, Novato, USA), coated with a thin gold layer by using an 
Edwards Scancoat (Edwards Laboratories, Milpitas, USA) six Pirani 501 
sputter coater.  
Chlorite dismutase was buffer exchanged to 50 mM ammonium acetate pH 
6.8 using centrifugal filter units with a cut-off of 30kDa (Millipore, UK). 
Crystal structure of Cld, a detoxifying enzyme producing molecular oxygen 
 69 
Chlorite dismutase was analyzed at a monomer concentration of 5 μM. To 
produce intact gas phase ions from large complexes in solution, the source 
was operated at a pressure of 6.7 mbar 15. Mass spectra were recorded with a 
capillary voltage of 1.3 kV and cone voltage of 200 V. The ToF pressure 
was 1.2 10-6 mbar. Spectra were mass calibrated using an aqueous solution 
of CsI (25 mg/ml).  
 
5.2.4 Tandem Mass Spectrometry 
Tandem mass spectra were recorded on a modified Q-ToF 1 instrument 
(Waters, UK) in positive ion mode. The pressure in the source region was 
increased to 10 mbar. Xenon was used as collision gas at a pressure of 1.5 
10-2 mbar. The capillary voltage and cone voltages were kept at 1400 and 
175V respectively. The collision voltage was varied from 10 to 200V.  
 
5.2.5 Activity assay with the Clark oxygen electrode 
Cld activity was measured amperometrically by the evolution of O2 using a 
modified Clark electrode (YSI) with home-made instrumentation, a 
Labview interface (National Instruments) and home-made Labview data 
acquisition and analysis software as described previously 16. The assay was 
performed in 100 mM KPi, pH 7.0 at 25 °C. After removal of oxygen by 
bubbling with high-purity argon, NaClO2 was added to 6mM final 
concentration. The reaction was started by adding 2-8 nM (final 
concentration) of Cld.  
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5.2.6 EPR spectroscopy and redox titration 
To determine the midpoint potential of the haem iron of Cld, an EPR 
monitored redox titration was performed in an anaerobic glovebox (Coy). 
The titration buffer was 50 mM KPi pH 7.2 with 10 % glycerol. A mediator 
mix was prepared in the same buffer containing per 100 ml 2.6 mg 
N,N,N',N'-tetramethyl-p-phenylenediamine, 5.2 mg dichlorophenol 
indophenol, 5.4 mg phenazine ethosulfate, 6 mg methylene blue, 3.8 mg 
resorufine, 7.5 mg indigodisulfonate, 2.8 mg 2-OH-1,4-naphtaquinone, 5.3 
mg anthraquinone-2-sulfonate, 5.2 mg phenosafranin, 5.6 mg safranin O, 
4.6 mg neutral red, 6.6 mg benzyl viologen and 5 mg methyl viologen. To 
the titration vessel 0.32 ml 1.5 mM Cld, 1.0 ml mediator mix and 1.28 ml 
titration buffer were added. The titration cell was connected to a reference 
Ag/AgCl electrode (SSE) and a platinum wire electrode. The electrodes 
were connected to a voltmeter. The potential was varied using sodium 
dithionite and potassium ferricyanide as reductor and oxidator, respectively. 
At various potentials, samples of 200 μl were taken from the titration vessel, 
transferred to an EPR tube, and immediately frozen in liquid nitrogen. EPR 
data were recorded on a Bruker ER200D EPR spectrometer with Labview 
interface (National Instruments) and home-made Labview data acquisition 
and analysis software, the liquid helium cooling was as previously described 
17. The microwave frequency was measured with a HP5350B microwave 
frequency counter. The modulation frequency was always 100 kHz. 
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5.2.7 Crystallisation 
The crystallisation of Cld has been published in details elsewhere 12. In 
short, after optimisation trials, dark red cubic crystals up to approximately 
100 × 100 × 100 m3 in size could be grown from well solutions containing 
100 mM MES buffer pH 5.5, 25 % (w/v) PEG MME 2000, 0.3 M KSCN, 
5% (v/v) glycerol and 160-260 mM (NH4)2SO4. The crystals were soaked in 
a solution containing the mother liquor including 16% glycerol prior to data 
collection. 
 
5.2.8 Crystallographic data collection and processing 
A MAD dataset was collected on beam-line ID23-1 at the European 
Synchrotron Radiation Facility (ESRF) at a wavelength of 1.7382 Å (peak), 
1.7399 Å (inflection point) and 0.98340 Å (high energy remote) using the 
anomalous signal of the iron atoms. The crystal was flash-frozen and kept at 
100K during data collection and 360 images were collected for the peak and 
inflection point and 185 images for the high energy, all with a rotation angle 
of 1º. Reflections were integrated with MOSFLM 18 and merged with 
SCALA 19 from the CCP4 suite 20. For data statistics see Table I and 12. 
 
5.2.9 Structure solution and refinement 
The structure was built automatically, with over 90% of the residues 
correctly docked, with the Crank 21 structure solution suite (version 1.2.0) 
using the three wavelength MAD data. Crank used Scaleit 20 for scaling the 
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data sets, Afro (Pannu, in preparation) for Fa estimation, Crunch2 22 for 
substructure determination, Bp3 23 for phasing, Solomon 24 for 
enantiomorph determination and density modification and Buccaneer 25 with 
Refmac5 26 using the MLHL function 27 for automated model building and 
refinement. 
Manual rebuilding of the model and addition of the unbuilt residues was 
done with COOT 28. Refinement to 2.1 Å resolution was done using 
REFMAC including NCS restraints for residues 10-217 and 231-248 and 
water molecules were added using COOT. Illustrations were prepared using 
PyMOL 29.  
 
5.3 Results and Discussion 
5.3.1 Structure determination 
The structure of Cld was determined by three-wavelength multiple 
anomalous dispersion (MAD) using the anomalous signal from iron atoms. 
The Cld crystallised in space group P21212, with unit cell dimensions of 
164.46 x 169.34 x 60.79 Å. The crystals contained six molecules in the 
asymmetric unit, which results in a solvent content of 52.6 % and a Wilson 
temperature factor of 26.6 Å2. The electron density map for each monomer 
showed clear density of residues 8-217 and 231-248 (monomer A), 9-217 
and 228-248 (monomer B), 10-217 and 229-248 (monomer C), 8-217 and 
229-248 (monomer D), 8-217 and 229-248 (monomer E), 9-217 and 231-
248 (monomer F). All monomers contain one protoporphyrin IX (haem) and 
one thiocyanate in the active site. In all but one monomer (monomer D 
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Table I  Crystallographic data and refinement statistics 
 
 Peak set Inflection point  High energy remote 
A. Data collection 
Beam-line ESRF ID23-1 ESRF ID23-1 ESRF ID23-1 
Wavelength (Å) 1.7382 1.7399 0.9834 
Resolution range (Å) 50-2.7 (2.85-2.70) a 50-2.9 (3.86-2.90) 40.13-2.1 (2.21-2.10)  
Reflections 660269 (96695) 538131 (78769) 731403 (107833) 
Unique reflections 47838 (6864) 38886 (5579) 100003 (14403) 
Multiplicity 13.8 (14.1) 13.8 (14.1) 7.3 (7.5) 
Completeness (%) 100 (100) 100 (100) 100 (100) 
Mean ((I)/sd(I)) 25.1 (6.3) 25.3 (6.1) 15.8 (3.8) 
Rsymb (%) 10.7 (41.0) 10.9 (42.0) 10.5 (48.8) 
Rano (%) 3.8 (10.9) 3.4 (10.9) 4.3 (19.3) 
Ano multiplicity 7.2 (7.2) 7.3 (7.3) 3.7 (3.7) 
Ano completeness(%) 100 (100) 100 (100) 100 (100) 
 
B. Phasing  
Number of Fe-sites   6   
FOM Overall   0.214 
FOM  2.21-2.10 Å  0.04  
 
C. Refinement  
Resolution range (Å)  40.13-2.10 (2.15-2.10) 
No. of reflections used in refinement 94936 (6889 ) 
No. of reflections used for R-free 4994 (381) 
R-factorc  0.22 (0.25)  
R-free  0.25 (0.30) 
No. of protein / water atoms 10939 / 555  
Average B-value  protein / solvent (Å2) 26.3/ 27.0 
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Average B-value haem / HCO3
2   20.9/ 42.2 
 thiocyanate 20.1 
Ramachandran statisticsd (%) 94.7 / 5.3 / 0 / 0 
R.m.s. deviationse (bonds, Å / angles, °) 0.013 / 1.298   
 
a Values in parentheses are for the highest resolution bin, where applicable.  
b Rsym = Σh Σi |Ihi - <Ih>| / Σh Σi | Ihi |, where Ihi is the intensity of the i
th measurement of the 
same reflection and <Ih> is the mean observed intensity for that reflection.  
c R = Σ||Fobs(hkl) | - |Fcalc(hkl) || / Σ|Fobs(hkl) |.  
d According to the program PROCHECK 30. The percentages are indicated of residues in the 
most favoured, additionally allowed, generously allowed and disallowed regions of the 
Ramachandran plot, respectively.  
e Estimates provided by the program REFMAC 26.  
 
showed poor electron density) a hydrogen carbonate anion is present in 
close proximity of the haem. The final model has good stereochemistry and 
R-factors (Table I) and next to 10939 protein atoms it contains 6 haem 
molecules including 6 Fe3+, 6 thiocyanate molecules, 5 hydrogen carbonate 
anions and 555 water molecules.  
 
5.3.2 Quaternary state of Cld 
Cld forms a hexamer in the crystal. The six subunits form a 65 Å high ring 
with a maximum diameter of 90 Å. The inner diameter of the ring is 
approximately 20 Å (Figure 1). A surface area of ~ 3000 Å2 per monomer is 
buried, which is within the range of true oligomeric protein contacts rather 
than non-specific crystal packing artefacts 31. Previously, it was assumed 
that the wildtype and recombinant Cld from different sources formed 
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Figure 1 View of the chlorite dismutase quaternary fold. The six monomers are shown in 
different colors. The haem is depicted in sticks and colored grey in all monomers.  
 
tetramers 8;10;12;32;33. These molecular weight determinations were based on 
analytical gel filtration experiments that were calibrated with globular 
protein standards. However, the elution position of a protein on a gel 
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filtration column is not correlated with molecular weight but instead is a 
function of the Stokes radius 34. Employing this relationship, it was found 
that the Cld ring structure present in the crystal elutes at the same elution 
volume as a globular tetramer would (Figure S1A and S1B).  
In order to obtain a more accurate quaternary state determination of Cld in 
solution, native mass spectrometry was performed. The mass spectrum 
illustrates that the multimeric species of Cld in solution is preserved as a 
pentameric complex ion in the gas phase (Figure 2A). The monomeric mass 
of Cld shows two peaks with a 134 Da difference, which was interpreted as 
a loss of the N-terminal methionine during expression (Figure 2B). Using 
tandem mass spectrometry the stoichiometry of the Cld oligomer was 
confirmed to be a pentamer. By collisional activation of the ions a single 
highly charged monomer was ejected from the pentamer. Concomitantly the 
low charged tetramer counter complex ions were also observed.  
It may be that the thiocyanate ion present in the crystallization condition 
affects the quaternary structure of Cld. Thiocyanate is a lipophilic ion that 
has the capacity to interfere with ionic pairs located either on the protein 
surface or the hydrophobic core of folded proteins. Moreover, thiocyanate 
dependent changes in quaternary state have been observed with 
flavoproteins previously 35;36. Low concentrations of thiocyanate did not 
affect the quaternary state, judged by mass spectrometry. Concentration 
levels of thiocyanate similar to that present in the mother liquor are too high 
for MS analysis.  
 
 







Figure 2 Native mass spectrometry of Cld. a) Main mass spectrum of Cld 
electrosprayed from an aqueous ammonium acetate solution. b) Close-up of the indicated 
region of the main spectrum showing the Cld monomeric mass.  
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5.3.3 Structure overview and the active site 
The Cld monomer has an + structure consisting of an eight-stranded 
antiparallel -sheet forming a -barrel with the -helices lying next to these 
sheets on the outside of the protein (Figure 3A). Each Cld monomer consists 
of two similar structural domains with a ferredoxin-fold (Figure 3B). 
 
Figure 3 Cld secondary 
structure and haem cavity. a) View 
of the chlorite dismutase overall 
fold. The α helices and β strands are 
labelled according to the ferredoxin 
fold and colored light blue and 
purple, respectively. The haem is 
colored red with the coordinating 
thiocyanate in yellow and blue 
(nitrogen atom). The amino acids 
forming the hydrogen bond network 
(see also Figure 2) are located within 
the boundaries of the grey frame. 
The hydrogen carbonate anion 
located next to 6, is colored in 
orange. In monomer A between 
**(Leu217) and *(Phe229) a part of 
the structure is not present due to a 
highly disordered loop. The picture 
was prepared with PyMol 29. 
 




Figure 3 (continued) b) Topology diagram of chlorite dismutase. The α helices are 
depicted as cylinders and colored light blue, the β strands are depicted as arrows and 
colored purple. The 41	32	 and 85	76	 antiparallel β sheet is a distinct feature. The 
topology diagram has been prepared using TopDraw 37. 
 
A single ferredoxin-fold contains a beta sheet formed by four antiparallel -
strands 38. In a Cld monomer the -barrel is formed by the 41	32	 -sheet 
from one domain and the topologically equivalent 85	76	 sheet from the 
other (haem binding) domain. A haem (protohaem IX) is bound in a well-
defined pocket between beta strands (5-8) and alpha helices (6-9). This 
pocket is accessible from the inner channel as well as from the outside of 
the hexameric ring (Figure 3C). The surface of the cavity is created by 31 
conserved, mainly hydrophobic residues (boxed residues in Figure 4). The 
iron atom in the haem cofactor is coordinated by His170 and (in our 






Figure 3 (continued) c) Left: surface representation of three monomers viewed from 
the inside of the ring, perpendicular to the 6-fold non-crystallographic axis. Right: rotated 
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180° counter clockwise around the 6-fold non-crystallographic axis, showing the outside 
surface of the hexameric ring. The electrostatic surface of subunit A (negative and positive 
charges are indicated with red and blue, respectively) is represented amid the two flanking 
subunits E and F (grey surface). This figure shows the solvent accessibility of the haem 
cofactor (red) and the bound thiocyanate molecule (green). A hydrogen carbonate anion 
(orange) binds near the haem cavity at the end of a striking deep groove, present on the 
outer surface of each monomer. d) Surface representation of the Cld cavity. Increasing 
distances from the haem cofactor to amino acid residues are shown in different colors: up to 
4 Å (light blue), 4-5 Å (marine blue), 5-6 Å (purple blue), and from 6-8 Å (dark blue). 
Residues further away from the haem are depicted in grey. This shows the binding pocket 
underneath the haem available for accomodating the ClO2. 
 
liquor at a concentration of 0.3 M. Cyanide is a strong inhibitor (100%) at 
20 mM concentration when the reaction was performed in the presence of 
15 mM chlorite 8 and we assume that thiocyanate is also an inhibitor of the 
reaction, indicating that the structure represents an inhibited state of the 
enzyme. Presumably, the thiocyanate will be replaced by chlorite in the 
reaction. To accomodate the substrate a small distal cavity about 2 Å deeper 
(purple blue) than the surface of the surrounding haem cavity (light blue) is 
present (Figure 3D). The two propionate groups of the haem cofactor 
(Figure 5A) form hydrogen bonds with 3 water molecules and amino acid 
Asn117, Tyr118, Ile119, and Trp155. Residues 117-119 are present in the 
loop between 4 and 6 which connects the two ferredoxin-like domains. 
The Trp155 residue, present in 7, is conserved in all aligned sequences and 
resides in close proximity to the heme propionate side chain (Figure 3A and 




Figure 4 Multiple sequence alignment of Azospira oryzae strain GR-1 Cld and 
related proteins using ClustalW 39 and GeneDoc 40. The numbering is according to the 
residue numbers of AoCld in the PDB (entry 2vxh). The first 6 sequences are chlorite 
dismutases from the different organisms: AoCld, Azospira oryzae strain GR-1, DspCld, 
Dechlorosoma sp. KJ, DaCld, Dechloromonas aromatica RCB, PcCld, Pseudomonas 
chloritidismutans, IdCld, Ideonella dechloratans, DgCld, Dechloromonas agitata. Signal  
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Figure 4 (continued) sequences were predicted using SignalP 41 and removed. BtDyp 
and SoTyrA are dye-decolorizing peroxidases from Bacteroides thetaiotaomicron and 
Shewanella oneidensis, respectively. Tt1485 is a hypothetical protein from Thermus 
thermophilus HB8 with remote homology to chlorite dismutase, suggested to function as a 
novel haem peroxidase. BsT0T is a putative Cld from Bacillus stearothermophilus with 
PDB entry 1t0t. PpMli is Pseudomonas putida muconolactone isomerase, a protein 
structurally similar to Tt1485. However, residues in the active sites of Tt1485 and PpMli 
are not conserved, implying that the proteins are not functionally related 42. Residues 
conserved in the aligned sequences are shown white on black (100% identical), white on 
grey (70%) or black on grey (50%). The residues in AoCld directly involved in haem 
binding are marked with asterisks while those forming the haem cavity are boxed. Note that 
Trp155 is a conserved residue in all sequences which partakes in formation of the haem 
pocket. The column labeled with ID% represents overall percentage sequence identity to 
AoCld.  
 
has been suggested to generate the EPR-active tryptophanyl radical 
appearing from a broad porphyrin 





Figure 5 Metal binding site and possible hydrogen bonds a) The haem is presented 
in sticks and colored red, the coordinating His170 is colored yellow (carbon), blue 
(nitrogen) and red (oxygen). The same coloring is used for the amino acids Ile 119, Tyr118, 
Asn117, Arg183 and Trp155. The coordinating thiocyanate is colored green and the waters 
(W) are depicted as blue circles. For reasons of clarity a part of the helix 8 (between the 
asterisks) has been omitted from this drawing. The possible hydrogen bonds are presented 
as black dots. b) Active site superposition of cytochrome c peroxidase (pdb code 2cyp; 
labels and residues in grey) and Cld (2vxh; labels in black and residues in color) made with 
Superpose 43. The proximal His, the distal Arg and the Trp residues near the haem 
propionate group occupy comparable positions in the active sites of both enzymes. 
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Figure 5 (legend on previous page) 
 
mixture 11. Strikingly, in cytochrome c peroxidase a tryptophan residue is 
situated adjacent to the heme propionate like in Cld. Moreover, based on 
kinetic data Cld is predicted to share functional similarities with heme-
dependent catalases and peroxidases 10. A structural alignment of the active 
sites of cytochrome c peroxidase and Cld shows a conserved arginine 
(residue 183 in Cld) at a similar position in the distal heme pocket (Figure 
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5B). The presence of a positively charged side chain can promote charge 
separation in the transition state. In cytochrome c peroxidase the distal 
arginine has a key role in activating the substrate and its sidechain shifts 
toward the active site in the presence of an anionic ligand 44. 
In Cld Arg183 is present in a rather striking conformation, at a distance of 
6.5 A from the iron atom. It seems to be displaced from the iron by the 
thiocyanate. Modelling indicates that in the absence of thiocyanate the 
Arg183 can approach the iron atom to a distance of 2.8 Å without changing 
the positions of main chain atoms. At a distance of 12 Å from the iron atom 
and 6.4 Å from Arg183, a hydrogen carbonate anion is located (Figure 3C; 
Figure S2), making a hydrogen bond (2.6 Å) with the backbone oxygen 
from Lys114. Inhibition studies on Cld have suggested the presence of a 
second, non-Fe coordinating site for ion binding in proximity of the heme, 
which would be necessary to accommodate the ClO until further 
recombination with Compound I 10. The identification of the anion binding 
site in the Cld crystal structure, currently accommodating the hydrogen 
carbonate, points at a catalytic mechanism via  ClO as proposed by Streit 
and DuBois 10 and recently experimentally supported by Lee et al. 11. 
 
5.3.4 Comparison with other structures 
The sequence alignment shows that Cld is a highly conserved protein in 
perchlorate respiring bacteria. This high similarity is also observed when 
comparing the 31 residues of the haem-binding site of AoCld with its 
homologues. Except P115, Y177 (identities in 4/6 Cld sequences) and L211, 
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M212 (identities in 5/6 Cld sequences) all these residues are completely 
conserved in the 6 Cld sequences shown (Figure 4). No significant 
homology to any other enzyme could be found using BlastP on all non-
redundant protein sequences in the NCBI database 45. The highest 
percentage identity, excluding Cld homologues, was 23% with a 
ferrochelatase from Propionibacterium acnes. Ferrochelatase catalyzes the 
insertion of ferrous iron into protoporphyrin IX as the terminal step in haem 
biosynthesis. However, this protein has a 3-layer  architecture with a 
chelatase-like fold (PDB code 1ak1) and did not show any similarity with 
AoCld using Superpose with secondary structure matching 43. Structural 
alignment of AoCld and proteins in the Protein Data Bank using the Dali 
server 46 revealed the highest similarity with two proteins of unknown 
function (1t0t and 1vdh) 42. The sequence identity for 1t0t and 1vdh 
compared to Cld is 16% and 12%, respectively. Both proteins were 
superposed onto Cld using Superpose with secondary structure matching 
(Figure 6). The main difference between the superposed structures is the 
orientation of the loop between 4 and 6, which is important for haem 
binding (Figure 5). This loop contains 3 of the 4 residues able to form 
hydrogen bonds with the two propionate groups of the haem. Both the 
protein structures of t0t and 1vdh were elucidated by X-ray crystallography, 
but both without haem present in the binding pocket. The putative Cld from 
Bacillus stearothermophilus with PDB entry 1t0t, present as a pentamer in 
the crystal, has not been described in literature. The protein from Thermus 
thermophilus HB8 (1vdh) was described as a pentameric complex in the 




Figure 6 Comparison of AoCld with two structural relatives. C superpositions of 
AoCld, a putative Cld from Bacillus stearothermophilus (pdb code 1t0t) and a suggested 
haem peroxidase from Thermus thermophilus remotely homologous to Cld (1vdh) showing 
that these enzymes share major structural features. Cld (2vxh) is shown in green, the 
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putative Cld (1t0t) in blue and the suggested haem peroxidase (1vdh) in magenta. The 
haem, only present in Cld (2vxh), is colored red. The main difference between the 
superposed structures is the orientation of the loop between 4 and 6 (labelling according 
to Figure 3a), which is important for haem binding. The Cld residues Asn117, Tyr118, and 
Ile119 are shown in yellow. The superposition was done with Superpose 43 using secondary 
structure matching and the picture was prepared using PyMol 29. 
 
Cld activity, indicating that 1vdh catalyzes a reaction other than Cld 42. 
Although the haem incorporating AoCld monomeric fold we report here is 
similar to crystal structures previously linked with Cld activity, the 
quaternary state is different. 
 
5.3.5 Redox properties of recombinant Cld 
An EPR monitored redox titration of recombinant Cld showed the existence 
of three different haem species (Fig. 7A and 7B; Fig. S3). First, a high-spin 
species with g-values (6.29, 5.46, 1.99), similar to wild-type Cld 9 and I. 
dechloratans Cld 47, which represents the five-coordinate ferric active form 
of the enzyme. Second, a low-spin species with g-values (2.97, 2.23, 1.49) 
similar to wild-type Cld with imidazole bound at the sixth coordination site. 
This species is most likely a remnant of the His-tag purification procedure. 
And finally, at relatively high potentials another low-spin species is 
observed, with g-values (2.90, 2.26, 1.55) which is indicative of a 
nitrogenous ligand at the sixth position. Presumably, this signal derives 
from a different protonation state of imidazole. In I. dechloratans Cld also a 





Figure 7 EPR spectroscopy and redox titration of Ao Cld. a) EPR spectrum of 0.18 
mM Cld poised at +32 mV. EPR conditions: microwave frequency, 9.388 GHz; microwave 
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power, 126 mW; modulation amplitude, 2.0 mT; temperature, 17.5 K. b) Redox titration of 
Cld.  five-coordinate haem,  imidazole adduct,  putative protonated imidazole bound 
enzyme. The datapoints are fitted to the Nernst equation for a one electron redox couple. 
Since the signal of the arginine bound enzyme contains a contribution of the imidazole 
bound enzyme, that signal is fitted to two independent one electron redox couples. 
 
enzyme, with g-values (3.04, 2.25, 1.52). This species, not present in the 
wild-type enzyme, was attributed to bis-histidine coordinated haem 47. 
The redox titration resulted in the following reduction potentials of the 
different haem species: -158 ± 9 mV for the five-coordinate Cld, -170 ± 6 
mV for imidazole bound Cld, and +22 ± 6 mV for the putative protonated 
imidazole bound Cld. The reduction potential for the recombinant Cld is 
135 mV lower than for the wild-type enzyme 9, which can be caused by 
subtle structural differences in the proximity of the haem. The reduction 
potential of haem iron in enzymes with a proximal histidine ligand is known 
to be modulated by the basicity of the proximal histidine 48. Furthermore, 
the wild-type enzyme, unlike the heterologously expressed enzyme, has 
been in contact with the highly oxidizing compounds (per)chlorate and 
chlorite during the cultivation of the organism. This has led to differences 
between native and recombinant versions of the same enzyme in some 
previous cases, notably also in I. dechloratans Cld 47. The low reduction 
potential of recombinant Cld results in a stabilization of the ferric state, 
which could be expected to be beneficial to its catalytic properties. 
However, the specific activity of the heterologously expressed Cld is similar 
to the wild-type enzyme 9. 
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By using the relationship between the reduction potentials of the ligand 
bound and free enzyme the ratio of the Kd values of the ferric and ferrous 
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From the Em of the putative protonated imidazole bound form we calculate 
that the Kd of this ligand for ferrous iron is 150 times lower than for ferric 
iron. This indicates a clear preference of the protonated ligand for ferrous 
iron.  
 
5.3.6 Cld catalytic mechanism 
The stoichiometry of the Cld reaction is 1 mol Cl and 1 mol O2 out of 1 
mol ClO2 8. Isotope experiments excluded water as a substrate of Cld, 
indicating that atoms in the oxygen gas product originate entirely from the 
ClO2 substrate 49. 
The haem groups in two adjacent monomers are too far away from each 
other (Fe-Fe distance ~ 31 Å) to suggest electronic interactions between the 
Fe centers. Furthermore, recent kinetic experiments on recombinant Cld 
from Dechloromonas aromatica RCB, which is 98 % identical in amino 
acid sequence to AoCld, show exponential decay of the enzymatic activity 
with increasing ClO2 concentration 10. Since cooperativity between the 
monomers in Cld would have led to a sigmoidal activity curve, this type of 
response to ClO2 binding could be ruled out. As a consequence, high 
valence states of the haem iron seem to be crucial for the transfer of the total 
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four electrons during one complete turnover, while the oxidation state of Cl 
in ClO2 changes from +3 to -1 in the Cl product.  
Previous spectroscopic and ligand-binding studies of AoCld suggested 
binding of chlorite to the five coordinate high-spin ferric form of the 
enzyme (or hexacoordinate with a weak sixth ligand) as the first step of the 
catalytic mechanism. The accessibility of the ferric iron centers was shown 
using the substrate analog nitrite which produced a low-spin species upon 
binding to the ferric form of Cld 9. The current crystal structure confirms 
that all haem groups in the Cld molecule are solvent accessible, both from 
the outside and the inside of the protein ring. 
Hagedoorn found optical and EPR spectroscopic evidence for the formation 
of a hydrogen peroxide Cld complex, which showed a decrease in the ferric 
signal and appearance of a radical signal in the EPR spectrum 9. Based on 
these results and the necessity of high valence states of the haem cofactor, 
we assumed the oxidation of the ferric iron center to an intermediate 
oxoferryl complex (FeIV=O) like compound I or II 50. George 51 discovered 
that ClO and ClO2 were able to form compound I and II in the haem 
enzyme horseradish peroxidase. Very recently, both compound I and a 
compound II-associated tryptophanyl radical signal have indeed been 
observed using EPR on a freeze-quenched Cld sample containing its 
substrate chlorite 11. 
The positively charged guanidinium group at the distal haem site makes 
Arg183 an ideal candidate to align and activate the ClO2 in the active site 
before oxidation. The ClO then released needs to be captured and stabilized 
by an amino acid nucleophile, presumably a nitrogen or oxygen atom. The 
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backbone oxygen of the strictly conserved Lys114, which is part of the 
anion binding site, is positioned near the haem edge and might fulfill this 
function. A mode of recombining the oxygen atoms of Compound I and 
ClO to give the reaction products has been proposed to occur via a 
peroxyhypochlorite intermediate. A nucleophilic attack of ClO onto the 
electrophilic compound I oxygen could produce this intermediate species 
before recombination to molecular oxygen, Cl and concomitant return to 
the ferric starting state of Cld 11. 
 
5.4 Conclusion 
Cld is a haem-based enzyme that selectively and effectively detoxifies 
chlorite with concomitant O-O bond formation. The removal of the by-
product chlorite is essential for survival of perchlorate and chlorate respiring 
bacteria. Cld from different sources has been described as a tetramer in its 
native state. However, in our crystal we observed a hexameric Cld ring. 
Based on the size of the solvent-accessible surface area buried after 
interaction between the six monomers, the hexamer was classified as a 
possible quaternary biological assembly. Re-interpreting our 
chromatographic data we found that based on the experimentally determined 
elution position, Cld could also be a pentameric or hexameric ring. Native 
mass spectrometry using a multimeric sample with high enzymatic activity 
demonstrated the presence of a molecular weight corresponding to a Cld 
pentamer. Taken all these data together, we conclude that the pentamer is an 
active state of Cld in solution. We cannot exclude the hexamer to be another 
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biologically relevant quaternary state although it was impossible to measure 
its activity due to the presence of the thiocyanate inhibitor. However, since 
cooperativity between the Cld monomers has been excluded based on 
kinetics results, indicating the monomers independently catalyse chlorite 
reduction, the precise quaternary state of the enzyme may be less relevant 
for enzymatic activity. In this case, different quaternary states might be 
biologically relevant and enzymatically active. For example, there may be 
an equilibrium between two states, with a transition influenced by protein 
concentration, pH or a small molecule or an ion 52;53. 
The crystal structure of the inhibited, haem incorporated Cld presented here, 
gives the first insights into the active site of the O-O bond formation and 
points at some key residues. A strictly conserved histidine (His170) is the 
axial haem ligand, while a strictly conserved arginine residue (Arg183) 
occupies a similar position in the distal part of the active site as Arg48 in 
cytochrome c peroxidase. Arg183 most likely has an essential role in 
substrate positioning and activation, as the homologous arginine residue in 
cytochrome c peroxidase. Trp155, another strictly conserved residue in Cld 
has been identified on geometrical grounds as the electron donor for the 
reduction of compound I to compound II. Trp155 is also part of the 
hydrogen bond network that binds the haem cofactor. 
The identification of an anion binding site near the haem is an important 
finding for the interpretation of the catalytic mechanism. The assumed 
mechanism involving a compound I intermediate would also generate a 
ClO anion which must remain close to the active site to perform its 
nucleophilic attack on the oxy-iron species. 
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On the basis of the EPR monitored redox titration, the reduction potential 
for the recombinant Cld haem appeared 135 mV lower than for the wild-
type enzyme. However, this does not result in a higher specific activity, as 
could be expected from the stabilization of the ferric state. 
To conclude, our data support the proposed catalytic mechanism for O-O 
bond formation via high valent oxy-iron species and ClO. Furthermore, we 
have analyzed the active site of Cld and indicated some key residues for 
chlorite conversion. Our work demonstrates that a unique biological 
function, chlorite detoxification, has led to a unique haem enzyme. 
A combination of site directed mutagenesis with spectroscopical and 
structural approaches is now necessary to complement the current catalytic 
mechanism. Pre-steady state kinetics experiments should be performed to 
study the formation of the Cld-ClO2 intermediates. 
 
Coordinates  
Coordinates and structure factors have been deposited in the Protein Data 
Bank (accession code 2vxh).  
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Figure S1. Determination of the quaternary state. Calibration curves created with 
size exclusion chromatography on a Superdex column. Data for molecular weights 
standards elution (open circles) have been fitted to the equations shown. 
a) The chromatographically determined Kav for Cld (closed circle) together with the 
calibration equation y = -0.3665x + 2.18 suggests a molecular weight of 105 kD which if 
one assumes a globular shape, would correlate with a tetrameric state of Cld in solution. b) 
The apparent molecular radius of 43 Å as calculated from the equation y = 0.0098x + 
0.2596 agrees very well with the value of 44 Å (closed circle) estimated from the crystal 
structure of the hexameric Cld ring (right inset) using Crysol software54. For completeness, 
a pentameric Cld constructed by superposing Cld subunits onto the putative Cld pentamer 
1t0t is also shown (closed triangle; left inset). The ring structures of Cld therefore elute at a 








Figure S2. Stereo representation of the anion binding site. Portion of the final 2.1 Å 
(2Fo − Fc) electron density map centered on the anion binding site, which is occupied by 
HCO3
−, contoured at the 1.0 level. 




Figure S3. EPR spectra of the samples of the redox titration of Ao Cld. EPR 
conditions: microwave frequency, 9.388 GHz; microwave power, 126 mW; modulation 
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Structural insight into the microtubule End Binding 
protein EB1 by small angle X-ray scattering: 
orientation of the microtubule binding and the coiled 















The end-binding protein 1 (EB1) is the archetypal member of a highly 
conserved group of proteins that uses its localization at the plus-ends of 
microtubules to regulate microtubule dynamics and chromosome 
segregation. EB1 contains an amino-terminal microtubule binding domain 
(En) and a carboxy-terminal dimerization domain (Ec). The latter domain 
can bind the p150Glued subunit of dynactin and the tumour suppressor 
protein APC. The crystals structures of both domains are known, but their 
relative orientation and the structure of the aminoacid sequence linking both 
domains is not. We used analytical ultracentrifugation, gelfiltration and 
small-angle x-ray solution scattering experiments to show that full the 
length EB1 is a non-globular dimer. In addition, the SAXS data provided a 
low resolution contour of the EB1 dimer as it exists in solution. We 
enhanced the resolution of this reconstruction by including the known 
crystal structures of the N- and C-terminal domains. A consistent picture 
emerges, whether or not the symmetry of the EB1 dimer is constrained. 
Essentially, the structure has the shape of a capital T, with the coiled-coil 
forming the stem of the T and the globular domains the cross. The two 
peptides linking the N-terminal to C-terminal domains generally lie in the 
plane of the T. The SAXS data do not provide sufficient resolution to 
distinguish the direction of the coiled coils, nor the orientation of the 
globular domains within the dimer. Nevertheless, the distance between the 
centers of gravity of the globular domains is about 80 to 90 Å. This is close 
to the distance between adjacent tubulin subunits along a microtubule 
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protofilament, thus suggesting a potential mode of binding of EB1 to the 
microtubule plus end.  
 
6.1 Introduction 
One of the prime regulators of microtubule dynamics is EB1. This end-
binding protein localizes specifically to the plus ends of microtubules 
(MTs). MTs, the tubular assembled form of tubulin heterodimers, mediate 
many essential processes in all eukaryotic cells, e.g. chromosome 
segregation. An important feature of the MT is its ability to assemble and 
disassemble from both sides: fast at the plus end and slow at the minus end. 
To assemble, the tubulin dimer needs to have bound GTP in the -subunit, 
which is hydrolysed shortly after the dimer is incorporated in the MT. The 
kinetics and conformation of tubulin are different for the GDP- and GTP-
forms: while GDP-tubulin dimers are bent and prone to depolymerise in the 
MT, the GTP bound state is straight and promotes polymerisation. Since 
tubulin adds to the MT plus-end as GTP-tubulin, a cap is formed that 
protects the MT from depolymerization. The tendency of GDP-tubulin to 
bend is constrained when incorporated in the MT by interactions with its 
neighbouring dimers, which implies that the energy of the GTP hydrolysis is 
stored in the MT lattice1-5. The standard free energy for hydrolysis of a MT-
bound nucleotide triphosphate is near-zero and the lattice stored energy is 
available to do work, as in chromosome movement4. When MTs 
disassemble, the lattice strain is rapidly released by the curling out of 
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protofilaments6;7. Alternating periods of growth and shrinking of the MTs 
result in the characteristic process referred to as dynamic instability.  
Antimitotic drugs interacting with tubulin disrupt the normal MT behaviour. 
Colchicine and vinblastine inhibit polymerization, while taxol prevents 
depolymerization of the MTs. Furthermore in the living cell MT dynamics 
is regulated by transcription of different tubulin isotypes, folding of /-
tubulin heterodimers, post-translational modification of tubulin, the 
nucleotide availability as well as the interaction with microtubule-associated 
proteins (MAPS)8. The MAPs including the motor proteins dynein and 
kinesin have been extensively researched for the last 20 years (see for 
exhaustive reviews Refs 8-11). A subset of the MAPS, the plus-end-
tracking-proteins or +TIPs accumulate specifically at the MT growing end 
and regulate MT dynamics. While EB1 is considered to be the prime +TIP, 
many interactions exist between EB1 and other proteins, suggesting it plays 
a central role in the regulation of the dynamic instability. This topic has 
been thoroughly reviewed (see e.g. Ref. 12). The fission yeast EB1 homolog 
Mal3p preferentially binds into specific sites that only form at the MT 
lattice seam. It has been suggested that more of these binding sites could be 
exposed at the growing plus-ends if the protofilaments are not yet laterally 
attached13, explaining the plus-end tracking behaviour of EB proteins. More 
recent sheet formation and closure by EB1 itself has been observed using 
electron cryomicroscopy14.  
Insight into the functioning of MTs is essential to understand the defects 
occuring in diseased cells. The aim of the work described in this chapter 
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was to structurally characterize EB1 and the complex EB1•p150GluedN to 
shed light on the mechanism of MT dynamics regulation. 
 
6.2 Experimental procedures 
6.2.1 Preparation of proteins and complexes 
Bovine liver catalase and horse muscle myoglobin were purchased from 
Sigma (Zwijndrecht, NL). 
Murine EB1 (residues 1-268) with His6-tag was expressed using a pET28a 
vector (Novagen, Germany) in the Escherichia coli host strain Rosetta 
BL21(DE3) pLysS. The vectors used for this research were kindly provided 
by Niels Galjart (Erasmus Medical Center, Rotterdam). Bacteria were 
grown at 37˚C in LB medium containing 50 mg/l kanamycin and 25 mg/l 
chloramphenicol and the cultures were induced at OD600 = 0.4 by adding 
IPTG to 1mM and incubated at 37˚C for 3 h. Cells were lysed in PBS buffer 
containing 1% Triton-X-100, by three times freezing in liquid nitrogen, 
followed by melting in a room temperature water bath, and sonication on 
ice. EB1 was pulled out of solution with a HisTrap HP column (GE 
Healthcare, Netherlands). After elution with Tris buffer containing 200 mM 
imidazole (pH 7.5), CaCl2 was added to 5 mM concentration and the His-tag 
cleaved off by thrombin (Roche, Germany) The protein was loaded onto a 
Q-Source column equilibrated with 20 mM Tris (pH 7.5) and eluted with 20 
mM Tris, 1 M NaCl (pH 7.5).  
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The protein was further purified by size exclusion chromatography with 
HiLoad 16/60 Superdex 200 prep grade using 20 mM Tris (pH 7.5) 
containing 150 mM NaCl and 1 mM DTT. The column (which had been 
calibrated beforehand with gelfiltration standards from Biorad) was eluted at 
1 ml/min. All purification steps were performed at 4˚C. EB1 was 
concentrated using Microcon concentrators (10 kD MWCO) and after snap-
freezing in liquid nitrogen, the  samples were stored at -80˚C until use.  
The N-terminal domain of rat p150Glued (residues 1-207 containing the 
CAP-Gly domain and an adjacent serine-rich domain) was purified in a 
similar way with the exception that an S-Source replaced the Q-Source 
column. The complex EB1•p150GluedN was prepared by adding purified 
p150GluedN to EB1 in a molar ratio 2:1, incubating the mixture on ice for 
ten minutes and running the sample on the equilibrated size exclusion 
column as described above. The identity and purity of the proteins and 
complex were routinely checked on Coomassie stained SDS PAGE gels and 
analysed with sedimentation velocity measurements.  
 
6.2.2 Sample preparation 
Catalase and myoglobin were dissolved at 20 mg/ml in 20 mM phosphate 
buffer containing 100 mM NaCl (pH 7.0). These solutions were dialyzed 
against the same buffer to remove traces of heavy metals. All protein 
solutions were filtered through an Ultrafree 0.22 m filter unit (Millipore, 
USA) before the SAXS measurements.  
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6.2.3 Analytical ultracentrifugation 
Sedimentation velocity experiments were performed using Optima XL-A 
and XL-I analytical centrifuges (Beckman-Coulter, Palo Alto, CA). The 
XL-A ultracentrifuge was equipped with a UV-visible absorbance detection 
system, while the XL-I had integrated absorbance and interference optics. 
The interference optics detected protein through changes in refractive index. 
The latter detection system allows a greater concentration range of 
macromolecules and larger data sets can be measured and analysed15. The 
sedimentation coefficient distributions were determined by direct linear 
least-squares boundary fitting using Sedfit16. All experimental s-values were 
corrected to the standard state of water at 20°C, which is necessary for 
comparative purposes of data obtained under different experimental 
conditions. The corrected s20,w values were calculated with the public 
domain software Sednterp (http://www.rasmb.bbri.org).  
 
6.2.4 SAXS data acquisition 
Small angle X-ray scattering measurements were conducted at the ESRF 
DUBBLE beam line BM26B (Grenoble, France) using 10 keV X-rays. 
Scattered X-rays were collected with a gas filled 2D Multiwire Proportional 
Counter positioned at a distance of 2 meters from the sample, covering the 
wave vector range 0.0008 < Q < 0.008 Å-1. Absolute values of the wave 
vector were obtained by reference to the orders of the 58.4 Å diffraction 
peak repeat in silver behenate17. The amplitude of the wave vector is defined 
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as Q = (4
/)sin(), 2 being the scattering angle. The cell, which contained 
approximately 100 l of sample between mica windows, was translated in a 
continuous movement during exposure to reduce radiation damage by the 
intense X-ray beam. Judging from the stability of intensity over time, the 
proteins suffered negligible radiation damage during a typical data 
collection of 60 frames of 10 s exposure each. All experiments were 
performed at room temperature. 
 
6.2.5 SAXS data treatment 
The SAXS data were processed using OTOKO18. The 2D images were 
reduced to scattering profiles by sector integration. Subsequently, these 1D 
curves were corrected for the beam intensity and the detector response. 
After averaging the buffer contribution was subtracted from each corrected 
scattering profiles using a published procedure19. The pair distribution 
function p(r), the forward scattering I(0) and the radius of gyration Rg were 
calculated using the program GNOM20.  
 
6.3 Results and Discussion 
6.3.1 EB1 and EB1•p150GluedN purification 
SDS-PAGE of EB1 purified by affinity, ion exchange and size exclusion 
chromatography indicated that the protein was >95% pure (Figure 1). The 
crystal structure of the coiled coil domain of EB1 (PDB code 1WU9) is a 
dimer21. However, the elution volume of EB1 during the final purification 
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step was smaller than expected for a globular dimer implying that either the 
native state of full length EB1 is larger than a dimer or that the EB1 particle 
is non-globular (Figure 2). The fractions containing EB1 were pooled and 
concentrated to 12 mg ml-1 for further analysis. 
The fragment p150GluedN eluted as a monomer during the final 
purification step and was concentrated to 23 mg ml-1. The complex 
EB1•p150GluedN was concentrated to 12.5 mg ml-1. 
 
Figure 1 SDS PAGE gel of 
samples after final gel filtration 
purification step. From left to right: 
marker proteins, full length EB1, 
p150GluedN fragment and the 
EB1•p150GluedN complex are shown 
 
 
6.3.2 Shape of EB1 from 
hydrodynamic data 
In a sedimentation velocity 
experiment a concentration 
boundary of macromolecules is 
formed that moves towards the 
end of the centrifuge cell as a 
function of time. The goal of the 
experiment is to determine the 
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Figure 2 Gel filtration of marker proteins (open circles) and EB1 (closed circle) on 
Superdex 200. Further details about the method are described in chapter 5 
 
sedimentation coefficient or s-value of the macromolecule (Table 1), 



















with u the observed radial velocity of the macromolecule,  the angular 
velocity of the rotor , r the radial position , 2r the centrifugal field, M the 
molar mass, v  the partial specific volume,  the density of the solvent, NA  
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Table I  Experimentally determined s-values after correction to water at 20°C 
 
Sample Mr s20,w (S) 
EB1 64 359 3.7 
p150GluedN 23 723 1.6 
EB1•p150GluedN 111 805 4.2 
 
Avogadro’s number, f the frictional coefficient, D the diffusion coefficient 
and R the gas constant.  
The inclusion of the molecular parameter f offers the possibility to combine 
the Svedberg equation with Stokes equation (see Ref. 15) yielding an 
expression for the maximum s-value that can be obtained for a protein of 











A compact sphere (with the volume of the true molecule and radius r0) has 
the minimum frictional coefficient f0 for a molecule with that given mass. 
The ratio of the experimental frictional coefficient f to the minimum 
frictional coefficient (f/f0), measures the maximum shape asymmetry from a 
sphere and is equal to the ratio of the maximum s-value to the observed s-
value (ssphere /s20,w). In case of EB1 the frictional ratio value calculated with 
the sedimentation constants is f/f0 = ssphere /s20,w = 5.7/3.7 = 1.9. This 

















Figure 3 Distance distributions function, P(r) versus r, for EB1. 
 
An independent value of the frictional ratio is obtained from the elution 
behaviour of EB1 on the Superdex column since f/f0 = Rs/r0 
22. As expected 
for a series of globular proteins a plot of log Mr versus the elution volume is 
a straight line. The point for the EB1 dimer deviates from this line (Figure 
2) which indicates that its shape is not globular. The Stokes radius Rs is 
defined as the radius of a sphere that is hydrodynamically equivalent to the 
true molecule. A sphere of that radius would have the same frictional 
coefficient f as the molecule. The Rs = 46 Å is read from the calibration line 
shown in Chapter 5 Figure S1 using the experimentally determined Kav = 
0.293 for EB1. The r0 calculated from the molecular weight and partial 
specific volume equals 26.6 Å. Therefore f/f0 = 1.7.  
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Both the ultracentrifugation and gel filtration data consistently indicate that 
EB1 is a non-globular protein. 
 
6.3.3 SAXS data 
A real space representation of the SAXS data was obtained by indirect 
Fourier transform of the scattered intensities, I(Q), using the GNOM 
program. The resulting P(r) function is essentially a histogram of the 
distances between all possible pairs of points in the molecule, for each pair 
indicating the probability that the corresponding distance indeed occurs 
within the molecule. The P(r) function for the EB1 dimer shown in Figure 3 
clearly indicates that it is an asymmetrical particle. 
 
Table II  Experimentally determined structural parameters from solution scattering 
 
Sample Rg (Å) Dmax (Å) 
EB1 41.1 ± 0.5 140 ± 5 
p150GluedN 24.9 ± 0.7 40 ± 1 
EB1•p150GluedN 30.5± 1.5  145 ± 5 
 
The overall structural parameters obtained from the EB1 scattering profile 
are Rg = 41.1 ± 0.5 Å and Dmax = 140 ± 5 Å. The Dmax value points at an 
elongated EB1 particle. The radius of gyration, Rg, is a geometric 
measurement defined in the same way as the radius of inertia in mechanics: 
the root-mean square of the distances of all the electrons of the particle from 
its centre of electronic mass 23. The analysis of the SAXS measurements on 
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the p150GluedN fragment and the EB1•p150GluedN complex is still in 
progress. However the preliminary structural parameters shown in Table 2 
are consistent with what would be expected. Since complex formation does 
not result in a significantly larger Dmax for EB1, the added mass of the 
p150GluedN fragment must be located relatively close to the center of mass 
of the EB1 dimer. Consequently the Rg value for the complex is smaller 
compared to the EB1 dimer. 
The 3D domain structure of EB1 was modelled on the basis of the SAXS 
data, using the high resolution models of the EB1 En and Ec domains 
employing the program Bunch. A simulated annealing protocol calculates 
the optimal positions and orientations of the domain structures and attaches 
dummy residues to the appropriate domain termini. The conformation of the 
dummy residues is adjusted to fit the experimental scattering data. Since the 
Ec domain shows P2 symmetry in the crystal structure, Bunch was run both 
with and without symmetry restrictions, point groups P1 and P2 
respectively. The resulting P2 models converged to two populations. The 
first and major population showed En domains in close proximity to the 4-
helix bundle of the Ec domain (Figure 4a). In the remainder (~ 40% of the 
models) the En domains were closer to the N-termini of the Ec domain 
(Figure 4b). The distance between the centers of gravity of the two En 
domains is approximately 80-90 Å in nearly all P2 models. This is strikingly 
close to the distance between two tubulin -subunits along a microtubule 
protofilament. Without symmetry restrictions three sets of models were 
found. Next to the two solutions described above, a new asymmetric 
conformation appeared with one En domain close to the N-terminus of the 
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Figure 4 Comparison of representative examples of EB1 models obtained with 
SAXS data employing Bunch. The known structures of the two globular En and the rod-
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shaped Ec domain are shown in grey, the linker domain in green and the C-terminal acidic 
tail in blue 
 
Ec domain and the other En domain near the Ec C-terminal end. It has been 
shown before that GTP hydrolysis is required for plus-end tracking and it 
was suggested that EB1 specifically recognizes a distinct lattice structure at 
the growing MT end24. Recently the antibody hMB11 specific for the GTP 
or GDP-Pi-bound tubulin conformation became available. In addition to the 
MT tip staining predicted by the classical GTP cap model, hMB11 labeled 
long stretches in areas where MTs formed bundles. Whether the GTP 
conformation is the cause or the consequence of bundling remained 
unknown. However, if the MTs retain the GTP conformation due to 
bundling specific binding proteins could be involved25. It is interesting to 
note that EB1 has a bundling effect on MTs26-28. Our structural data suggest 
that EB1 binds to a dimer in a protofilament. EB1 could recognize the GTP 
or GDP-Pi-bound tubulin conformation in the MT like the antibody hMB11 
does. Through binding EB1 could stabilize the GTP or GDP-Pi 
conformation and support the anchoring of a protofilament into the MT 
lattice. Further studies will be needed to characterize the precise localization 
of EB1 on microtubules. Since several conformations of EB1 are found 
using SAXS, further investigation of the domain orientation using other 
techniques, e.g. FRET or mild crosslinking followed by digestion and mass 
spectrometry, would be useful.  
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Verschillende biologische systemen, zoals het 50S ribosomale Hsp15 
complex, een schistosomiasis diagnostisch antigen bindend antilichaam 
fragment (Fab 54-5C10-A), het zuurstof producerende enzym chloriet 
dismutase (Cld) en het belangrijke regulatoreiwit van microtubule dynamiek 
(EB1) zijn onderzocht met geavanceerde biochemische technieken. De 
structurele informatie verkregen met electronenmicroscopie (EM), kleine 
hoek verstrooiing van Röntgenstraling (SAXS) en Röntgendiffractie aan 
individuele eiwitkristallen werd aangevuld met informatie uit andere 
biofysische en biochemische methoden, zoals kolom chromatografie, gel 
elektroforese, oppervlakte plasmon resonantie (SPR), massa spectrometrie 
(MS) en electron paramagnetische resonantie (EPR). 
 
Hoewel de in dit proefschrift beschreven biologische systemen uiteenlopen 
wat betreft chemische samenstelling, oorsprong en biologische functie, is er 
juist ook gekeken naar een gemeenschappelijk kenmerk: geïnduceerde 
conformatieveranderingen binnen het eiwit, eiwit-RNA of eiwit-
carbohydraat complex. 
In het geval van het ribosomale 50S gedeelte, wat ontstaat als een 
translaterend bacterieel ribosoom uiteenvalt door bijvoorbeeld 
temperatuursverhoging, zorgt het relatief kleine eiwit Hsp15 door binding 
met de 50S subeenheid voor een essentiële verandering. In hoofdstuk 2 
wordt beschreven hoe het tRNA door Hsp15 wordt gestabiliseerd in de P-
locatie waardoor de A-locatie beschikbaar komt voor een release factor. De 
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release factor kan nu de laatste peptidyl-tRNA binding van de onvoltooide 
eiwitketen hydrolyseren waarna het vrije polypeptide en het tRNA molecuul 
kunnen wegdiffunderen van de 50S subeenheid. Het 50S RNA-
eiwitcomplex is dan gereed voor hergebruik als belangrijkste component 
van het ribosoom. 
Hoofdstuk 3 heeft een toegepaste, praktische achtergrond. Het geeft een 
beschrijving van de kristalstructuur van het antilichaam fragment wat wordt 
gebruikt om de diagnose te stellen van de tropische, parasitaire ziekte 
schistosomiasis (ook wel bilharzia genoemd). Uit de oppervlakte plasmon 
resonantie experimenten blijkt dat de aanwezigheid van tenminste drie 
Lewis X eenheden een vereiste is voor de vorming van een antilichaam-
antigen complex. De kristalstructuur, in combinatie met docking studies, 
laat zien hoe het betreffende antilichaam 54-5C10-A een trimeer Lewis X 
suiker kan binden. Analyse van de stabiliserende interacties tussen eiwit en 
koolhydraat maakt duidelijk dat niet alleen alle zes CDRs maar ook alle drie 
opeenvolgende Lewis X eenheden een rol spelen bij de complexvorming. 
Het lijkt erop dat ook ketens die bestaan uit meer dan drie repeterende 
Lewis X zouden kunnen binden, een conformatieverandering van CDR-H3 
zou ervoor kunnen zorgen dat de bindingsplaats verruimd wordt. Van 
andere antilichamen is bekend dat CDR-H3 wel tot 15 Å kan opschuiven. 
In hoofdstuk 4 en 5 komt een conformatieverandering ter sprake die van 
geheel andere orde is. In deze twee hoofdstukken wordt het Cld enzym 
beschreven, een eiwit wat op een uiterst effectieve manier de giftige stof 
chloriet omzet in de alledaagse, onschadelijke stoffen zuurstof en chloride. 
Voor de bacterie waaruit Cld het eerst gezuiverd is, Azospira oryzae, is dit 
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enzym essentieel om chloriet onschadelijk te maken. Dit chloriet wordt 
gevormd als metabolisch tussenproduct wanneer de bacterie perchloraat of 
chloraat gebruikt als electronenacceptor. In het eiwitkristal blijkt Cld als 
hexamere ring voor te komen, terwijl het in oplossing een pentameer is. 
Hoogstwaarschijnlijk zorgt één van de componenten die nodig is voor het 
kristalliseren van Cld, thiocyanaat, ervoor dat de quaternaire toestand 
verandert. 
Hoofdstuk 6 beschrijft de lage resolutie structuur van het eiwit EB1. In de 
literatuur is gesuggereerd dat een gedeelte van een belangrijk 
motoreiwitcomplex wat bindt aan EB1, p150Glued, de EB1 conformatie zou 
kunnen veranderen. Dus is ook het complex van EB1 met bindende gedeelte 
van p150Glued gezuiverd. De lage resolutie structuur van dit 
EB1•p150GluedN complex laat zien dat er geen grote 
conformatieverandering plaatsvindt ten opzichte van de EB1 structuur. Met 
de gebruikte SAXS techniek kunnen geen hoge resolutie structuren 
verkregen worden, maar wel kunnen bijvoorbeeld kristalstructuren in de 
SAXS electronendichtheidsmap gefit worden. Als dit gedaan wordt met de 
kristalstructuur van het microtubulus bindende domein van EB1, blijkt de 
afstand tussen deze twee identieke domeinen in de EB1 dimeer overeen te 
komen met 80 tot 90 Å. Dit benadert de afstand tussen naast elkaar gelegen 
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